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Here we present a minimal mathematical model for the Sphingomyelin synthase 1 (SMS1)
driven conversion of ceramide to sphingomyelin based on chemical reaction kinetics. We
demonstrate, via sampling-based parameter estimation and mathematical analysis, that
this model is not able to qualitatively reproduce experimental measurements on lipid com-
positions after altering SMS1 activities. We conclude that a positive feedback mechanism is
required from the products to the reactants of the reaction, which in fact exists in vivo via
protein kinase D and the ceramide transfer protein CERT. Accordingly, a modied model
that comprises this feedback mechanism was able to reproduce experimental ndings.
iii AbstractSommario
In questa tesi presentiamo un modello matematico minimo per la conversione di un ce-
ramide in sngomielina catalizzata dall'enzima sngomielina sintasi 1 (SMS1) basato sulle
leggi della cinetica chimica. Viene dimostrato, utilizzando tecniche di sampling per la
stima parametrica e metodi di analisi matematica, che questo modello non  e in grado di
riprodurre qualitativamente delle misure sperimentali sulla composizioni dei lipidi in se-
guito ad alterazione dell'attivit a enzimatica di SMS1. Concludiamo quindi che  e necessario
considerare un meccanismo di feedback positivo fra i prodotti e i reagenti della reazione,
che esiste eettivamente in vivo tramite la proteina chinasi D e la proteina di trasporto
di ceramide CERT. Di conseguenza, proponiamo un secondo modello modicato in modo
da comprendere questo meccanismo di feedback, che risulta essere in grado di spiegare i
risultati sperimentali.
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The process of secretion of proteins in mammalian cells is one of the most highly controlled
processes of living beings, since it underlies the regulation of a lot of biochemical functions
throughout the entire organism. A detailed understanding of the secretory pathway and of
the underlying regulatory network is the basis for targeted intervention and is thus highly
relevant for pharmaceutical applications.
The use of formal mathematical models to describe complex biochemical reaction net-
works is an important approach to study the properties of such biological systems, and to
be able to simulate the eects of external intervention.
The main focus of this thesis is the systematic study of the functioning of a small
but relevant subsystem of the secretion regulatory pathway at the trans-Golgi network:
the enzymatic conversion of ceramide to sphingomyelin driven by the catalysing enzyme
sphingomyelin synthase 1 (SMS1). In particular the aim is to propose an ordinary dier-
ential equation (ODE) model to formally describe the biochemical reactions under study
and to partially validate the model by tting it to a given experimental dataset, using
sampling-based statistical approaches for parameter estimation. Discrepancies encoun-
tered between simulated model predictions and experimental observations have led to the
formulation of a nal model, which considers a particular positive feedback mechanism
between two reactants of the reaction. Using mathematical analysis we demonstrate that
the proposed model including such feedback regulation is sucient to qualitatively repro-
duce experimental measurements on lipid compositions after altering SMS1 activities. This
theoretical result is supported by an improved statistical model t.
12 Introduction
In Chapter 1 we introduce some general biological notions concerning the secretion
of proteins. We give a brief idea of the underlying regulatory network and we highlight
in particular the role of the reaction of interest in the regulation of secretion: the SMS1
driven conversion of ceramide into sphingomyelin at the trans-Golgi network. Moreover
we present how chemical reactions can be modelled with ordinary dierential equation
systems. Chapter 2 presents in more detail the reaction of interest, and the related param-
eterized ODE system. From some experimental ndings we can show that, considering the
reaction in isolation, the simple model is not able to capture the presented experimental
data, and that there is the need to develop a modied model that takes into account a
positive feedback regulation between two reactants of the reaction. We conclude this Chap-
ter with a mathematical proof of this theory, rejecting analytically the rst model, while
showing that the introduction of a feedback control ensures a qualitative explanation of
the experimental ndings. These theoretical expectations were tested against experimental
data by applying, for parameter estimation, the statistical inference approach of the max-
imum likelihood estimation, and a sampling-based Bayesian approach, whose theory and
results are presented in Chapters 3 and 4, respectively. These results conrm our theoreti-
cal investigations supporting the hypothesis of the feedback regulation, while rejecting the
model without feedback. The sampling method provides also interesting results concerning
model predictions and further information about the distribution of parameters, through
the marginal posterior density functions.Chapter 1
Biological context
In this Chapter we want to give a general overview of the biological context underlying
this thesis, focusing on the description of the process of secretion of proteins in mam-
malian organisms and on the explanation of the functioning of the enzymatic reaction that
metabolises sphingomyelin from ceramide, driven by the enzyme sphingomyelin synthase
1, that takes place at the trans-Golgi network. In particular we want to highlight the
connection between the biochemical reaction of interest and the control of the secretory
pathway.
Afterwards we want to brie
y present the basic concepts of the mathematical modelling
of cellular biochemical reactions by means of ordinary dierential equation systems, that
will be used in our subsequent analysis of Chapter 2.
34 1 Biological context
1.1 Biological background
1.1.1 Regulation of secretion of proteins in mammalian cells
Most human cells secrete proteins. Secretory proteins include many hormones, enzymes,
toxins, and antimicrobial peptides and they are synthesized in the endoplasmic reticulum
(ER). When they are assembled and folded correctly they are transported to the Golgi
apparatus by means of special vesicles. Passing through the cisternae of the Golgi apparatus
these proteins are further elaborated. In particular at the trans-Golgi network proteins to
be secreted are sorted and segregated from lysosomal enzymes. When they are ready for
secretion, secretory proteins leave the Golgi apparatus, packed in specialized vesicles, to be
transported towards the cellular membrane. Finally the vesicle membrane fuses with the
cell membrane and so the proteins leave the cell. This last process of fusion of the vesicle
with the plasma membrane and the following release of its contents is called exocytosis.
More detailed informations about the process of secretion can be found in [5] and [27, Chap.
8]. In Figure 1.1 the main steps of the secretory pathway are graphically represented.
This complex secretory process is highly controlled and regulated at dierent stages
within mammalian cells. In particular we mention an important regulation mechanism,
based on the interdependence of protein kinase D (PKD) and of the ceramide transport pro-
tein CERT, which in
uences the formation of secretory vesicles at the trans-Golgi network
(TGN). In fact PKD has been identied as a crucial regulator of the secretory transport
at the TGN [9]. Recruitment and activation of PKD at the TGN is regulated by binding
with the lipid diacylglycerol (DAG) [3], a pool of which is produced by sphingomyelin
synthase (SMS) from ceramide (Cer) and phosphatidylcholine (PC) taking place at the
TGN. The non-vesicular transfer of ceramide from the endoplasmic reticulum (ER) to the
Golgi complex is mediated by the ceramide transport protein CERT [19, 20, 21, 22, 23].
Moreover CERT is critical for PKD activation and for PKD-dependent protein transport
at the plasma membrane. Thus the interaction between PKD and CERT has a key role
for the maintenance of Golgi membrane integrity and secretory transport [9].1.1 Biological background 5
Figure 1.1: Representation of the secretory pathway within human cells: secretory proteins
are synthesized in the ER, transported to the Golgi apparatus, where they are post-modied
and sorted, and nally, packed in specialized vesicles, transported to the plasma membrane.
Copyright c 
The McGraw-Hill Companies, Inc.
1.1.2 Sphingomyelin synthase 1: SMS1 driven conversion of ce-
ramide into sphingomyelin at the TGN
Due to the facts described at the end of the previous Subsection, we maintain that an
interesting subsystem of the secretion regulatory network to analyse is the metabolic con-
version of ceramide (Cer) into sphingomyelin (SM) catalysed by the enzyme sphingomyelin
synthase (SMS) at the TGN, yielding diacylglycerol (DAG) as a side product [33, 37].6 1 Biological context
Each organism capable of SM production displays a multiplicity of SM synthase (SMS)
genes. The mammalian genome contains two SMS isoforms, named SMS1 and SMS2. SMS1
and SMS2 are co-expressed in a wide range of human cell types and the corresponding
enzymes reside in organelles where SMS synthesis is known to occur: SMS1 is localised to
the Golgi, while SMS2 resides primarily at the plasma membrane [25, 44]. Moreover they
operate as the key Golgi- and plasma membrane-associated SM synthases, respectively
[39].
Now we want to present in detail the enzymatic reaction taking place at the trans-Golgi
network, referring in this way specically to the enzyme SMS1. In fact, in the study of the
regulation of protein tracking and secretion, we have prevalent interest in the reaction
taking place at the Golgi apparatus, and in this work we will not consider the reaction
localised at the cell membrane.
The enzyme \Sphingomyelin Synthase 1" (SMS1, UniProt identier: Q86VZ5) consists
in a transmembrane protein, with sequence length of 419 amino acids, and molecular mass
of 49,208 kDa. SMS1 is an integral membrane protein of the trans-Golgi membrane [25, 39].
It is supposed that SMS1 possesses six transmembrane domains and that both the carboxy
terminus and the amino terminus face the cytoplasmic side of the trans-Golgi membrane
[25]. Instead the potential catalytic amino acids of SMS1 are probably oriented towards
the lumen side, the exoplasmic lea
et, of the trans-Golgi membrane.
SM synthesis is mediated by a phosphatidylcholine:ceramide cholinephosphotransferase,
i.e. SM synthase 1, and the reaction takes place in the lumen of the trans-Golgi [25]. It
consists in an enzyme that catalyses the transfer of a phosphocholine head group from
phosphatidylcholine (PC) to ceramide, thus generating SM and DAG [25, 38]. Moreover
SMS1 is also able to catalyse the reverse reaction at the trans-Golgi membrane, namely
the formation of PC and ceramide from SM and DAG. For this reason SMS1, rather than
functioning strictly as SM synthase, is a bi-directional transferase capable of using PC or
SM as phosphocholine donors to produce PC or SM, and the specic direction depends on
the relative concentrations of DAG and ceramide as phosphocholine acceptors present in
the membrane, respectively [25]. Some studies provide also evidence that SMS1 represents1.1 Biological background 7
a major SM synthase activity in mammalian cells, compared to SMS2, with a critical role
in cell growth [38, 39].
Figure 1.2: Putative reaction mechanism of
SMS1-mediated SM synthesis (Figure 3 in
[38]).
The putative reaction mechanism of the
SM synthesis catalysed by SMS1 proceeds
through the following steps, as outlined in
Figure 1.2 [25, 38]:
1. binding of a two-chain choline phos-
pholipid, PC or SM, to a single bind-
ing site of the enzyme SMS1;
2. the phosphocholine head group of the
donor is transferred to a conserved
histidine residue in the enzyme's ac-
tive site;
3. formation of DAG or ceramide ac-
cording to the used phosphocholine
donor, and release of the produced
DAG or ceramide, while the head
group stays bound to the enzyme;
4. the phosphocholine head group is
transferred to the phosphocholine ac-
ceptor bound to the enzyme, ce-
ramide or DAG, forming SM or PC;
5. release of the synthesised SM or PC
from the active site of the enzyme to
allow another round of catalysis.
As already highlighted all steps in this reaction mechanism are reversible, thus satisfying
the experimental observation that SM and DAG can also be converted to PC and ceramide.8 1 Biological context
1.2 Modelling cells as systems
The main goal of the quite recent eld of research named \Systems Biology" is the sys-
tematic study of complex biological systems using the precise mathematical structure of
Systems Theory, and at the same time cooperating with the advanced experimental knowl-
edge and results of Biology.
In order to study complex relations between biochemical networks of reactions and to
describe them in a mathematical way, it is important to structure the problem in a simple
way. Some basic hypotheses and simplications are needed to allow quantitative under-
standings and realistic predictions of cellular processes and of the underlying regulatory
mechanisms. For more details about this whole Section we refer to standard texts such as
[1, 2] and [32].
1.2.1 Biochemical reactions
The dynamics of intracellular processes, such as signal transduction or metabolic pathways,
are often described by homogeneous systems of chemical reactions, named chemical reaction
networks (CRN). In this simplied modelling approach, the cellular system is considered
as a homogeneous system, and concentration gradients or spatial dierences are ignored.
Some examples of such chemical reaction equations are:
 degradation of molecules, A   ! ;
 dimerization (reversible), 2A     * )     A2
 activation (e.g. phosphorylation), A     * )     A
 more complex reversible reactions, 2A + B     * )     C
where A;B;C represent the molecular concentrations of three dierent reactants. In gen-
eral the single arrow indicates that the reaction can go only one way, while the double
arrow symbol indicates that the reaction is reversible.1.2 Modelling cells as systems 9
1.2.2 ODE models based on chemical reaction kinetics
In order to dene the dynamics of cellular reactions, translating chemical reaction systems
into ordinary dierential equation (ODE) models, we have to determine the velocity of
each chemical reaction, named reaction rate. In this way we can express the conversion
rate at which a particular reactant's concentration changes, d
dt[A(t)], where [A(t)] is the
concentration of the molecular species A as a function of time.
The \law of mass action" (LMA) is a standard way to assign reaction rates to chemical
reactions, allowing the construction of dierential equation systems. ODE models are
deterministic models, and they are appropriate to describe the behaviour of an average cell
or a cell population, rather than a single cell. Formally, the law of mass action states that
the rate at which a reaction takes place is proportional to the product of the concentrations
of the molecular species participating in the reaction. The factor of proportionality is called
reaction rate constant.
To make some examples we present the reaction rates relative to some simple chemical
reactions (with the cursive capital letters in the rate equations indicating the concentrations
of the reactants):
A
k   ! Rate: v = kA (1.1a)
A + B
k   ! Rate: v = kAB (1.1b)
2A + B
k   ! Rate: v = kA
2B (1.1c)
where we employ the law of mass action. We can dene all quantities v also with the concept
of 
ux, in the sense of velocity at which the molecular mass of the reactant changes in a
time unit. Applying these rules, and considering all 
uxes contributing to the conversion
rate of each specic reactant, we are able to translate complex chemical reaction systems
into parametric ODE systems.10 1 Biological context
For example, for a generic reversible reaction such as 2A + B
k+     * )    
k 
C the corresponding
ODE model reads:
_ A(t) =  2k+A
2B + 2k C (1.2a)
_ B(t) =  k+A
2B + k C (1.2b)
_ C(t) = k+A
2B   k C: (1.2c)
1.2.3 Michaelis-Menten enzyme kinetics
Now we brie
y present one of the most used models for enzymatic reactions, proposed
by Michaelis and Menten (1913), which describes the conversion of a substrate S into a
product P, via an enzyme catalyst E. For details we refer to the texts [1, 2, 32].
In this reaction the substrate S reacts with the enzyme E, and they bind to form an
intermediate complex C, that can reversibly dissociate to form again S and E. Finally the
complex C decays into a product P and the original enzyme E. The considered chemical
reaction is:
S + E
k1     * )    
k 1
C
k2   ! P + E (1.3)
The reaction rate constants are dened as k1, k 1 and k2. Instead of formulating the
complete ODE model corresponding to this chemical system, we are going to simplify the
equations through some hypotheses in order to express the reactions in a single dierential
equation, the so-called Michaelis-Menten (MM) enzyme kinetics.
We assume that the reaction C
k2   ! P + E is slow compared to the time scale of the
reversible reaction S + E
k1     * )    
k 1
C. This assumption leads to the so-called \Quasi-steady
state approximation" (QSSA). This means that the fast reversible reaction is always in
equilibrium (with slowly changing substrate concentration). Considering the total amount
of the enzyme ET, that represents the sum of the free molecules E and the ones bound
to the complex at steady state CS, and solving the dierential equation for the product P
with respect to the substrate concentration S, we obtain the desired MM equation:
_ P = k2  CS = k2 
ET  S
Km + S
: (1.4)1.2 Modelling cells as systems 11
The constant Km is called Michaelis-Menten constant and it equals:
Km =
k  + k2
k+
: (1.5)
To conclude this topic we highlight the fact that for small concentrations of the substrate
S the MM kinetics provides a linear relation between the synthesis rate of the product P
and the substrate level. Instead at high concentrations of the substrate, in particular for
S  Km, this relation becomes a constant, i.e. the synthesis rate is no more in
uenced by
dierences in the levels of the substrate and the enzymes are limiting.12 1 Biological contextChapter 2
SMS1 reaction system
The enzyme sphingomyelin synthase (SMS) uses ceramide and phosphatidylcholine as sub-
strates in the reaction that synthesizes sphingomyelin and diacylglycerol, as described in
detail in Chapter 1, Section 1.1, from a biological point of view.
The concentrations of SMS1 and SMS2, the two isoforms of mammalian SMS, play a
fundamental role in the control of SM, DAG and ceramide levels within human cells, and
is thus strongly related with a lot of important cellular functions, as it will be described in
Section 2.1.
The main focus of this Chapter is to present a mathematical dynamical model (ODEs)
of the subsystem of the secretion regulatory pathway catalysed by SMS1 at the trans-
Golgi network, based on chemical reaction kinetics. The aims are to investigate the role
of SMS1 activity, to understand the underlying relations between educts and products of
this reaction and to describe as good as possible experimental data taken from biological
literature.
1314 2 SMS1 reaction system
2.1 Impact of SMS on multiple cellular functions
Sphingomyelin (SM) is the most abundant sphingolipid species in mammalian cells, com-
prising 5-15% of total phospholipids [39], and it represents an important component of
cellular membranes.
As already described in Chapter 1, SM sythase (SMS) is a class of enzymes that catal-
yse the reaction that produces SM from ceramide, by transferring a phosphocholine head
group from phosphatidylcholine (PC) to ceramide, with the additional production of dia-
cylglycerol (DAG) as byproduct, an important bioactive lipid. Therefore this enzyme plays
a central role in the metabolism of sphingolipids and glycerolipids reacting together, which
are involved also in dierent important cellular processes [38, 39]. In nature there exist
two known isoforms of human SMS, named SMS1 and SMS2. They reside in dierent or-
ganelles, where SM synthesis in known to occur: SMS1 is located on the cis-medial aspect
of the Golgi apparatus, and SMS2 on the plasma membrane [25].
Several biological ndings show that the concentrations of these two isoforms of SMS,
expressed in all major human tissues [25], are fundamental for the control of the endogenous
levels of the lipids taking part in this reaction, in particular ceramide, SM and DAG, at
the Golgi apparatus and at the plasma membrane, respectively [8, 39, 42]. The articial
manipulation of both enzymes can in principle in
uence the metabolism of all four bioactive
lipids participating in the reaction, and thus we assume that SMS behaves as an important
potential regulator of many cellular processes linked to these particular lipids.
Ceramide is a proapoptotic factor and has antimitogenic properties while DAG behaves
as a mitogenic factor, i.e. that induces mitosis, the process in cell division in eukaryotes in
which the nucleus divides to produce two new nuclei, each having the same number and
type of chromosomes as the original. Moreover DAG, gathered in subcellular pools at the
Golgi apparatus, binds with protein kinase D (PKD) mediating in this way its recruitment
at the trans-Golgi, where, once activated, it eciently regulates the formation of Golgi-
derived secretory vesicles that are specically destined to the cell surface [3], a process that
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Finally SM has a high-packing density when accumulating in the plasma membrane,
and a high anity with cholesterol, contributing in this way to the barrier function of
the membrane. Cooperating with cholesterol and glycosphingolipids, SM has a strong
ability to form lipid \rafts" in the plasma membrane [36] 1, which are known to have an
important role as a platform for signal transduction and protein sorting and tracking in
cell membranes.
Some interesting publications, which we are going to illustrate, maintain that SMS is
involved, via regulation of endogenous levels of those lipids, in the regulation of multiple
biological cellular functions, such as: signal transduction, functional modulation of cell
membrane structure, in particular of plasma membrane lipid rafts [28], cell proliferation,
dierentiation, apoptosis [8], cell growth and survival [39], PKD recruitment at the TGN
and activation [39, 42], which in turn is tightly related with regulation of secretion [3, 9].
Since in this study we are specically interested only in the reaction that takes place
at the trans-Golgi apparatus, where SMS1 is located, from this point forward we will refer
mainly to the experiments and results relative to this SMS isoform, avoiding to mention
the information concerning the other enzyme SMS2.
In the study of Tafesse et al. [39] human cervical carcinoma HeLa cells underwent RNA
interference, in order to specically deplete SMS1 and SMS2 expression. Their analysis
focused to grasp the eects of these manipulations on the Golgi- and plasma membrane-
associated SM synthase activities, SM production levels, overall lipid composition and
cell growth. After 7 days of siRNA (small interfering RNA) treatment, the SM synthase
activity in SMS1-depleted cells was reduced by 80% respect to control cells. The impact of
this SMS1 depletion on the total lipid composition of HeLa cells was a 20% reduction in SM
levels compared with controls and a 1.8-fold increase in ceramide levels. The decrease in
SM levels seemed to the authors quite minor compared with the strongly reduced enzyme
SMS activity. They state later that this is due to a growth arrest of the cell, which is
accompanied by a general down-regulation of phospholipid synthesis. The eect on the
1The \rafts" are cholesterol- and SM-enriched membrane regions, also known as liquid-ordered domains
[36], which are known to have an eect on multiple signaling pathways.16 2 SMS1 reaction system
levels of PC, cholesterol and DAG was not signicant. The last impact of SMS silencing
underlined in [39] by the authors was the connection between SMS and growth in HeLa
cells. In fact a growth arrest occurred in cells treated with SMS1 siRNAs within 3 days
after transfection2, regardless of the culture conditions. A 2-fold increase in cells undergoing
apoptosis was also observed.
Ding et al. [8] proposed some experimental results that demonstrate that SMS1 and
SMS2 are key factors in the control of endogenous cellular SM and DAG levels and further-
more that there exists an important relationship between SMS activity and cell apoptosis.
The experimental ndings about the eects of SMS1-expression modulation on the lipid
composition of the cells will be described in detail in Section 2.3, since we will use these ex-
perimental data for the validation of the model and for parameter estimation. To evaluate
the role of SMS in apoptosis, the authors in [8] applied SMS1 and SMS2 gene overexpres-
sion and silencing techniques to CHO cells and THP-1-derived macrophages, respectively.
The overexpression led to an increase in the SMS1 activity and signicantly higher intra-
cellular SM, DAG and ceramide levels with respect to controls. CHO cells overexpressing
SMS1 were more likely to undergo lysis mediated by lysenin, proving SM enrichment of
the plasma membrane. Then they showed an incrementation of plasma membrane lipid
rafts and of tumor necrosis factor--induced apoptosis, compared with wild-type CHO
cells. On the other hand, SMS1 siRNA was used to knock down SMS1 activity in human
macrophages. This led to signicantly reduced intracellular and plasma membrane SM
levels, reduced DAG and ceramide levels, and nally a decreased rate of LPS-mediated
macrophage apoptosis, compared with the control case. Change in the dierences in cel-
lular PC levels was not signicant in both cases of overexpression and silencing. Finally
the authors suppose that both SMS1 and SMS2, regulating SM and DAG levels, could
contribute to change lipid rafts on the plasma membrane and thus aect protein kinase C
(PKC) activity in certain disease states [15, 26].
2Transfection is the process of deliberately introducing nucleic acids into cells. The term is used notably
for non-viral methods in eukaryotic cells. Genetic material (such as plasmid DNA or siRNA constructs),
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As last work we consider the one of Villani et al. [42]. In this study the authors inves-
tigated the role of the enzymes SMS1 and SMS2 on the regulation of DAG by modulating
their expression. In particular they inquired into the possibility that SMSs could mod-
ulate subcellular pools of DAG, once acute activation of the enzymes is induced. Their
experimental results showed that regulation of SMS aected the formation of DAG at the
TGN, and SMS knockdown reduced the recruitment of the DAG-binding protein PKD at
the Golgi apparatus. These ndings proved that both enzymes are able to regulate the
formation of DAG in HeLa cells, that this pool of DAG is biologically active and directly
implicate SMS1 and SMS2 as regulators of DAG-binding proteins at the Golgi apparatus.
All of these ndings demonstrate that an important relationship exists between SMS
activity and cell membrane SM concentrations and thus between SMS activity and cellular
functions. In particular manipulation of SMS1 cellular levels, exclusively located at the
trans-Golgi apparatus, in
uences the secretion of proteins through the regulation of local
lipid pools (DAG) and their consequent eects on protein kinase D (PKD) and ceramide
transfer protein (CERT) [41].
2.2 Chemical reaction and ODE model
2.2.1 Chemical reaction
As starting point for the construction of a dynamic mathematical model that describes the
conversion of ceramide (Cer) into sphingomyelin (SM) in dependence of the activity of the
enzyme SMS1, we consider the following chemical reaction:
Cer + PC )          
p2,SMS1
p1,SMS1
              * DAG + SM (2.1)
The SMS1 driven reaction is reversible and this fact is represented by the double arrow
between the two substrates (Cer and PC) and the two products (SM and DAG), where
the parameters p1 and p2 indicate the forward and backward reaction rate constants. It is
however known that eectively, in vivo, the net reaction is always to the right, since SM is18 2 SMS1 reaction system
constantly removed from the Golgi apparatus to form the vesicles that transport secretory
proteins to the plasma membrane [41].
To complete the graphical representation of this chemical reaction we need to take into
account some further biological knowledge. In fact this is not a closed subsystem and
there are some in- and out
ows that have to be further considered. Thus there is no mass
conservation of the four reactants participating in the reversible reaction, and the net 
ux
of the entire reaction does not constantly equal zero, i.e. the dierence between the two
unidirectional 
uxes of the reactions does not vanish.
Describing the reaction using mass action kinetic, lipids' concentrations reach a steady
state value, and the corresponding derivatives are zero. However the eective in vivo
situation is a \dynamic" equilibrium, due to these 
uxes that are constantly carried into
and out from the system [41].
First of all there is an in
ux Cin of ceramide, that represents the quantity of this
sphingolipid that is produced at the endoplasmic reticulum (ER) and transported, through
the ceramide transfer protein (CERT), to the Golgi apparatus, where the reaction occurs.
For now we consider this 
ux as a constant value, postponing the consideration that the
in
ux Cin could be a function of other chemical reactants.
Then we consider for every reactant, except for PC, a simple linear degradation factor,
that takes into account both the degradation and the out
ux due to transportation, like
in the case of SM.
Finally we assume the concentration of phosphatidylcholine (PC) to be constant, ac-
cording to some experimental results taken from the literature, which show that the concen-
tration of PC does not signicantly change if the value of SMS1 is manipulated [8, 39, 42].
This assumption can be interpreted as a dominant regulation of PC by other chemical
pathways, which balance the eect of SMS1, or by a large overall pool of PC, which does
not notice changes of small fractions [41].
Taking all these eects into account, the chemical reaction of interest can be represented
like in Figure 2.1.2.2 Chemical reaction and ODE model 19
Figure 2.1: SMS1 driven conversion of ceramide to sphingomyelin.
2.2.2 Parameterized dierential equation model
Referring to the chemical reaction just described, we now want to develop a dynamical
model for this process of the form _ x = f(x;), using mass action kinetics to translate
chemical reaction systems into ordinary dierential equations systems, as described in the
introductory Chapter 1, Section 1.2. In this way we obtain a deterministic mathematical
model for the biochemical system in the form of dierential equations that represent the
rst derivatives w.r.t. time of the concentrations of the reactants taking part in the reaction.
To describe the two enzymatic forward and backward reactions with two substrates we
use Michaelis-Menten enzyme kinetics, presented in Chapter 1, Section 1.2. Our theoretical
analysis about the dynamical ODE system are, however, independent of the exact choice of
the functions modelling these 
uxes, and they could be represented with two generic 
uxes
v1(SMS1;Cer;PC) for the forward reaction, and v2(SMS1;DAG;SM) for the backward
one, expressions that we will consider in the last Section 2.4 of this Chapter. To simplify
the notation we dene the concentration of ceramide with the initials C, and moreover we
write simply SMS to express the total concentration of the enzyme SMS1.
This model will be of course a function of a certain number of parameters, namely: the
in
ux of ceramide (Cin), the reaction rate constants of the degradation eects (dC;dDAG
and dSM) and the two reaction rate and two Michaelis-Menten constants of the forward
and backward enzymatic reactions (p1;p2;k1 and k2).20 2 SMS1 reaction system
The developed parametric dierential equation system, for the lipids and proteins re-
acting together, is presented as follows:
_ C = Cin   dC C   p1 SMS
C  PC
C  PC + k1
+ p2 SMS
DAG  SM
DAG  SM + k2
(2.2a)
_ DAG =  dDAG DAG + p1 SMS
C  PC
C  PC + k1
  p2 SMS
DAG  SM
DAG  SM + k2
(2.2b)
_ SM =  dSM SM + p1 SMS
C  PC
C  PC + k1
  p2 SMS
DAG  SM
DAG  SM + k2
(2.2c)
_ PC = 0 (2.2d)
_ SMS = 0: (2.2e)
We present now a simplied and more compact version of this ODE model, that will be
considered for the future analysis and considerations about the system. This notation is
also used in Matlab for the computational simulations (see Appendix A).
First of all we set SMS1 = u, because it is the input (or control) of our system,
which is dened a priori to simulate dierent experiments. It expresses the \activity" of
the enzyme SMS1 compared to a reference situation, in the sense that its value is 1 in
the control case, and it can vary taking larger or smaller values, in dependence to which
experiment is considered. More precisely u > 1 in the case of SMS1 overexpression, and
u < 1 in the case of silencing (knockdown) of the enzyme, in the sense that consequently to
these manipulations the cellular SMS1 activity is subject to a u-fold increase or decrease.
We consider only the rst three dierential equations, considering u and PC among
the other parameters, given that their value remains constant by hypothesis. We redene
also the state variables as x = (x1;x2;x3) = (C;DAG;SM), and the three corresponding
degradation rates as d1;d2 and d3. In this way the system can be rewritten as follows:
_ x1 = f1(x) = Cin   d1  x1   p1 u
x1  PC
x1  PC + k1
+ p2 u
x2  x3
x2  x3 + k2
(2.3a)
_ x2 = f2(x) =  d2  x2 + p1 u
x1  PC
x1  PC + k1
  p2 u
x2  x3
x2  x3 + k2
(2.3b)
_ x3 = f3(x) =  d3  x3 + p1 u
x1  PC
x1  PC + k1
  p2 u
x2  x3
x2  x3 + k2
: (2.3c)2.3 Experimental data from literature 21
Our model is thus of the form _ x = f(x;), with the state: x = (x1;x2;x3) 2 R3
+,
belonging to the positive orthant of R3, referring to the fact that concentrations are positive
quantities, and the parameter being a 10-dimensional vector:
 = (Cin;p1;p2;d1;d2;d3;k1;k2;u;PC) 2 R
10
+ (2.4)
also made up of all positive quantities. The rst 8 parameters (Cin;p1;p2;d1;d2;d3;k1;k2)
will have to be estimated from experimental data taken from biological literature, that will
be described in the next Section 2.3, while u and PC have constant values dened by the
experimental conditions.
To complete this Section we list the units of measurement of the variables and param-
eters of the system. Since we will use non-dimensional values for all lipid concentrations
and for the input u by normalizing to some control measurement values, we assume the
variables x1;x2 and x3 and the two constants u and PC to be dimensionless. Consequently
k1 and k2 are dimensionless too, while Cin;p1;p2;d1;d2 and d3 are [min 1] 3.
2.3 Experimental data from literature
The aim of the deterministic mathematical model just presented is to predict, for specic
values of the 8 parameters,  = 0, real data of the concentrations of the four reactants
participating in the reaction, and in this way to describe in a formal way the dynamics of the
reaction. The rst step is thus to gather experimental datasets of the concentrations of the
reactants at particular instants of time, measured through biochemical experiments that
reproduce the enzymatic reaction in specic cells expressing human SMS1. The second step
is to estimate a specic value for the parameter vector , such that the model can explain
as good as possible the given data obtained under the specic experimental conditions,
and nally predict other datasets under dierent experimental conditions.
3We could generalize dening the unit of measurement of all these parameters as [time 1]. In fact we
are interested in the steady state values of the concentrations so we do not need a specic unit for the
time, and we could let it not specied.22 2 SMS1 reaction system
For this purpose we use some experimental datasets provided in [8]. In this article the
authors explain the eects of manipulation of both SMS isoforms, using gene overexpression
and knockdown techniques, on the levels within the cell of the following lipids: ceramide
(Cer), phosphatidylcholine (PC), diacylglycerol (DAG) and sphingomyelin (SM).
We will consider only the experiments concerning the manipulation of SMS1 activity,
and its in
uence on the metabolism of all four lipids of the reaction. That's because, as
already underlined in Section 2.1, we consider only the reaction that takes place at the
trans-Golgi apparatus, where this specic SMS isoform (SMS1) is located, while SMS2 is
located at the plasma membrane which is beyond the scope of this thesis.
2.3.1 Overexpression
Overexpression was carried out in genetically modied CHO (Chinese hamster ovary) cells,
that stably express human SMS1 and SMS2 [8]. This procedure increased SMS1 and SMS2
mRNA levels, and this fact resulted in an incrementation of cellular SMS activity, compared
with control CHO cells. In particular SMS1 overexpression resulted in a 2.2-fold increase
in cellular SMS activity, compared with wild type cells (Fig. 1B in [8]). Enzymatic assays
were used to measure cellular lipid levels, whose absolute values are reported in Table 2.1
(Table 1 in [8]).
Table 2.1: Lipid concentrations in CHO cells overexpressing SMS1.
Exp.# Type of cell u Cer PC DAG SM
1. Control 1 0:96  0:09 294  23 2:45  0:51 25  3
2. Overexpressing SMS1 2.2 1:38  0:08a 283  37 3:31  0:66a 31  3a
The units of measurement of all quantities are nmol/mg protein, and the values of the
concentrations of four lipids are given as mean  standard deviation (SD), and derived
from ve repeated experiments. The meaning of the superscript a in the second line of
Table 2.1 is that dierences between these data and the values of the control experiment2.3 Experimental data from literature 23
in the same column are statistically signicant (P < 0:01 by ANOVA and P < 0:05 by
Student-Newman-Keuls test).
As results in Table 2.1 show, cells in which SMS1 was overexpressed contained sig-
nicantly higher SM and DAG levels, as it was expected. Not expected instead was the
signicant increase of ceramide levels, compared with controls. Finally PC levels showed
no signicant changes between the control experiment and the one with overexpression.
This aspect was already considered in our mathematical ODE model, by dening the con-
centration of phosphatidylcholine as constant.
From data it was not possible for the authors in [8] to understand which particular
SM was increased by overexpression, representing SM levels reported in Table 2.1, the
total amount of SM present in all cellular membranes, including ER, Golgi apparatus and
also plasma membrane. With some further considerations the authors explain that SMS
overexpression increases the lipid rafts, or raft-like domains, in the plasma membrane. This
means that SMS overexpression has an important eect on SM levels specically in the
plasma membrane, where signal transduction begins, because it changes the overall cell
membrane structure [8].
2.3.2 Silencing
To further evaluate the relationship between SMS activity and cellular lipid levels, the
authors of [8] used SMS1 and SMS2 small interfering RNA (siRNA) to knock down the
respective mRNA in THP-1-derived macrophages, that are human macrophages. They
explain that one reason to use a dierent type of cells w.r.t. the overexpression experiment
is that hamster SMS1 and SMS2 cDNA sequences are not known, and so the siRNA
approach to knock down these two enzymes in CHO cells would not yet be plausible.
This procedure caused a signicant decrease in cellular SMS activity, in particular SMS1
siRNA reduced it by 23% compared with control cells (Fig. 4A in [8]). With enzymatic
assays they measured cellular levels for the same four lipids of interest, whose absolute
concentrations are shown in Table 2.2, as in the case of overexpression (Table 2 in [8]).24 2 SMS1 reaction system
Table 2.2: Lipid concentrations in SMS1 knockdown macrophages.
Exp.# Type of cell u Cer PC DAG SM
3. Control 1 0:77  0:06 320  33 2:26  0:12 44  5
4. SMS1 siRNA 0.77 0:73  0:09 339  19 1:71  0:23a 35  4a
From these data it results that total intracellular SM and DAG levels were signicantly
decreased in cells that had been transfected with SMS1 siRNA, compared with wild type
cells. Instead no signicant change was measured in ceramide cellular levels, as for PC
levels. Like in Table 2.1 concerning the experiment of overexpression, the units of mea-
surement of all quantities are nmol/mg protein, and the values of the concentrations of
lipids are given as mean  SD, and are the average of ve experiments. Also the meaning
of the superscript a is the same, indicating statistically signicant data compared with con-
trol in the same column (P < 0:01 by ANOVA and P < 0:05 by Student-Newman-Keuls
test).
2.3.3 Normalization of the two datasets
All the data relating to the four experiments (two controls, one overexpression and one
silencing) will be the starting point for the parameter estimation of the model.
In order to use these experimental data for this purpose, we interpret the measurements
as dynamic equilibrium states (steady states)  x(u) = ( x1(u);  x2(u);  x3(u)), functions of the
input u. In this situation the concentrations and hence the reaction 
uxes are constant,
i.e. _ xi = fi( x) = 0; 8i = 1;2;3. Nevertheless we have to consider that those datasets
are obtained from two dierent types of cells, Chinese hamster ovary cells and human
macrophages, respectively. In the two datasets concerning the two control experiments
(the rst and the third) in the two dierent kinds of cells, one can notice at once that the
absolute concentrations of all four reactants are quite dierent. Therefore the two datasets
given in Tables 2.1 and 2.2 are not consistent, being measured in two dierent cellular
systems. For this reason we cannot compare directly the absolute concentration values in2.3 Experimental data from literature 25
the parameter estimation procedure. To make our analysis possible and to be able to test
hypotheses across cell lines, we normalize the concentrations of every reactant, i.e. mean
and standard deviation, w.r.t. the corresponding value of the control experiment, namely
the mean value measured in the wild type cell. We do that separately for the two dierent
cells, so that all concentrations (the mean values) in the rst and third experiment will
be equal to 1, with normalized SD, and the ones in the second and forth experiment will
be normalized w.r.t. the control absolute levels. In Table 2.3 we present all these values,
which we will use for parameter estimation and further analyses. For the relative PC levels,
we consider only the normalized mean values and not the standard deviations, because in
the model we dene PC as a constant parameter, as we do also for u. In fact for each
experiment we dene the specic value of PC, and we do not consider it as a measurement,
like the other three lipids with statistical description, to be used for parameter estimation.
Every lipid normalized concentration reported in Table 2.3 is thus dimensionless, being
normalized w.r.t. control levels, and it justies the consideration made in Subsection 2.2.2
about the units of measurement of the state variables xi.
Table 2.3: Lipid concentrations for all 4 experiments normalised w.r.t. control levels in
wild type cells, relative to the same cell, expressed as mean value  SD.
Exp.# Type of cell u Cer PC DAG SM
1. Control 1 1  0:09 1 1  0:21 1  0:12
2. Overexpressing SMS1 2.2 1:44  0:08a 0:96 1:35  0:27a 1:24  0:12a
3. Control 1 1  0:08 1 1  0:05 1  0:11
4. SMS1 siRNA 0.77 0:95  0:12 1:06 0:76  0:10a 0:8  0:09a
In this way from now on we consider relative changes of lipid levels in response to
manipulation of SMS1 activity (overexpression and knockdown), and we analyse the be-
haviour of the model in a qualitative way. In fact this normalization has the eect that
both quantitative datasets relative to the two dierent cell types are transformed into one
rather semi quantitative dataset to test our hypothesis.26 2 SMS1 reaction system
2.4 Analysis of the ODE system
In this Section we want to make some simple considerations about the model before dealing
with the estimation of parameters and the problem of identication of parameters, that
will be discussed in the next Chapters.
We will prove that the hypothesis of a simple constant ceramide in
ux Cin is not
adequate to explain the qualitative trend of steady state levels in response to dierent
SMS activities.
For this reason we will present a second revised model, in which the constant ceramide
in
ux is replaced by an in
ux that is a function of another reactant (i.e. diacylglycerol),
taking the form of a feedback regulation term Cin(DAG) = f(DAG) between a product
and an educt. We will explain why a feedback of this form is the next logical extension
of the rst model, supporting this choice with eective biological ndings about the regu-
lation through diacylglycerol of the transport of ceramide at the TGN. We want to show
theoretically that this second modied model can better reproduce biochemical data in a
qualitative way.
2.4.1 Ceramide in
ux: feedback regulation?
Changes in the activity of the enzyme SMS1 produce the alteration of the 
uxes of the
reversible reaction (2.1), and consequently of the steady state concentrations of the four
reactants participating in the reaction. From experimental data, given in Tables 2.1 and
2.2, we can notice that the increase and decrease of SMS1 activity (u), produce a signicant
increase and decrease of SM and DAG cellular levels, respectively. This fact let us presume
that SMS1 overexpression increases the net 
ux of the reversible reaction to the right
side. Considering this statement as true, and under the hypothesis of constant Cin, we
conclude that ceramide level should decrease after SMS1 is overexpressed, and should
increase after the enzyme is knocked down, while we already know that PC level remains
almost constant following to u-level alteration [41]. In fact, if we consider the biochemical
reaction, represented in Figure 2.1, in isolation, the changes of steady state concentrations2.4 Analysis of the ODE system 27
of lipids SM and DAG after SMS manipulation should have opposite sign with respect to
the change of steady state ceramide level. This statement is also proven in Section 2.4 in
a formal mathematical way.
But if we consider the real trend of ceramide levels at steady state after overexpression
and silencing, looking at Table 2.3, we notice a completely dierent behaviour. In fact
in the case of overexpression the quantity  x1(u) (steady state concentration of ceramide)
signicantly increases, while in the case of SMS1 knockdown, it slightly decreases, although
not marked as signicant in [8].
In Table 2.4 we summarize the real trend of lipid concentrations at the equilibrium
after SMS manipulation (Data), together with the expected trend given by the model
(2.3) (Expected), highlighting with double arrows the contradiction in the ceramide's
trends.
Table 2.4: Trend of lipid levels compared to controls after overexpression and silencing:
comparison between trend of experimental data and what is expected from the ODE model
with Cin constant.
u  x1(u) (Cer)  x2(u) (DAG)  x3(u) (SM) PC
Overexpression: Data SMS1" * " " {
Overexpression: Expected SMS1" + " " {
Silencing: Data SMS1# { (+) # # {
Silencing: Expected SMS1# * # # {
In this way we can already underline that the rst model _ x = f1(x;), dened by the
equations (2.3), fails to explain experimental ndings qualitatively and we need to extend
our hypothesis, modifying the structure of the dierential equation system.
From biological knowledge we know that there exists an indirect feedback regulation
from DAG to the transport of ceramide to the TGN, via protein kinase D and the ceramide
transfer protein CERT (see the graphical scheme in [41]). Therefore we want to describe
this phenomenon in our dynamic mathematical model, trying to change the equations28 2 SMS1 reaction system
in order to explain qualitatively better the experimental results of the changes in lipid
composition in response to SMS perturbations, given in Table 2.4. In particular we assume
that the velocity of transport of ceramide to the TGN, where the reaction takes place,
represented by the in
ux Cin, is a function of the DAG concentration, becoming in this
way a term of the form Cin(DAG). Moreover we assume that this regulation takes place
without this last reactant being consumed, and hence we do not have to change or add
some extra terms in the other dierential equations of system (2.3).
In this sense we describe the indirect regulation from DAG to ceramide levels at the
TGN in a very simplied way. In fact the term Cin(DAG) summarizes all biochemical
reactions that occur in the pathway between DAG and Cer with a unique eective direct
regulation term [41].
One has to be aware of the strong simplication adopted in this context, but we will
show that it is sucient to explain qualitatively the experimental results of the changes in
lipid levels at the TGN consequently to SMS1 manipulation.
2.4.2 Choice of the feedback function Cin(DAG) = f(DAG)
The question that arises now is which function f(DAG) should be chosen to represent this
ceramide in
ux at the TGN, in order to explain experimental data in a proper way.
Unfortunately this indirect feedback eect that binds DAG levels at the TGN to the
transport of ceramide via CERT is not yet well understood in detail. Moreover this process
could be dierently regulated depending on the specic cellular system. What is known
is that DAG at the TGN can in
uence the transport of ceramide from the endoplasmic
reticulum to the Golgi apparatus both in a positive and in a negative way, trough dierent
chemical pathways, and for this reason it is not so clear how to represent this eect by a
mathematical function of the concentration of diacylglycerol, x2 in our model (2.3).
We try to approximate the relation between DAG levels at steady state and the in
ux
Cin, by comparing the outputs of the model (2.3) with the available lipid measurements
for the dierent experimental conditions, as it is shown in Table 2.4. From these data we2.4 Analysis of the ODE system 29
can understand that the feedback regulation function should be monotonically increasing.
First of all it can be observed that the concentration of ceramide at steady state  x1(u)
is monotonically increasing with Cin, ensured by the eect of mass balance considering the
system in isolation in a situation of dynamic equilibrium. Afterwards we can make the
following considerations: as depicted in the rst panel of Figure 2.2, we x a point in the
plane (DAG;Cin) that refers to the control experiment, ( xcontrol
2 = 1;Ccontrol
in ). In the case
of SMS1 overexpression the DAG level increases signicantly. This means that the net 
ux
increases to the right, with consequently more production of SM from ceramide. As we
already explained, without the feedback regulation there should be a consequent decrease in
the steady state level of ceramide, but the experimental results show an opposite behaviour.
For this reason we assume that an increased DAG concentration should also increase the
in
ux C
overexpr
in w.r.t. the control experiment (second panel of Figure 2.2).
In the opposite case of SMS1 silencing, the DAG level decreases signicantly compared
with the control level, due to a smaller net 
ux of the reversible reaction to the right
direction. In the hypothesis of constant in
ux Cin, ceramide levels at equilibrium should
increase, since it is less consumed by the reaction. But also in this case experimental
data give controversial results, since when SMS1 is knocked down the ceramide level at
steady state slightly decreases. This fact means that there should be a decreased in
ux of
ceramide C
silencing
in at the TGN with respect to the control case (third panel of Figure 2.2).
All these considerations bring us to assume that the function Cin(DAG) is monotoni-
cally increasing, and, in a rst attempt, the simplest approximation of such a function that
can be chosen is a linear one, as shown also in the last panel of Figure 2.2, of the form:
Cin(DAG) = f(DAG) = a  DAG a > 0: (2.5)30 2 SMS1 reaction system
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Figure 2.2: Steps for the choice of a linear feedback function Cin(DAG).
The second modied model _ x = f2(x;), with this new feedback function, reads as
follows (using the same notation of model (2.3)):
_ x1 = f1(x) = a  x2   d1  x1   p1 u
x1  PC
x1  PC + k1
+ p2 u
x2  x3
x2  x3 + k2
(2.6a)
_ x2 = f2(x) =  d2  x2 + p1 u
x1  PC
x1  PC + k1
  p2 u
x2  x3
x2  x3 + k2
(2.6b)
_ x3 = f3(x) =  d3  x3 + p1 u
x1  PC
x1  PC + k1
  p2 u
x2  x3
x2  x3 + k2
: (2.6c)
We could have added in equation (2.5) also a constant term, writing in this way
Cin(DAG) = a  DAG + b, avoiding to have for the new system a xed point in the
origin,  x = (0;0;0), and moreover having one more degree of freedom. But using the
parametrization of equation (2.5), we have in the model (2.6) the same number of param-
eters of the rst model (2.3), so that we can compare directly the goodness of the data ts
for the two models, without using other criteria of model comparison.
A short explanation is also needed for reasons about why we chose a linear approx-
imation of the feedback function. For example we could have chosen also functions of
higher orders, having no clear idea of how this feedback eect acts biologically on the
regulation of the transport of ceramide. With Matlab we carried out a maximum like-
lihood parameter estimation, method explained in Chapter 3, in order to estimate the
three dierent in
uxes for the three dierent experimental conditions: Ccontrol
in ;C
overexpr
in
and C
silencing
in . After plotting the three obtained Cin as function of the three respective2.4 Analysis of the ODE system 31
normalized DAG concentrations (the three normalized DAG measurements reported in
Table 2.3), which are represented in Figure 2.3 with three bold points (Data), we per-
formed a linear and quadratic interpolation of the three points, passing through the origin,
to compare which function could better represent the three available points. These two
dierent interpolations are also depicted in Figure 2.3, with a continuous straight line for
the linear interpolation and a dotted line for the quadratic one. As one can observe in the
gure the linear approximation is sucient to represent the feedback function Cin(DAG).
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Figure 2.3: Linear (continuous line) and quadratic (dotted line) approximations of the
feedback function Cin(DAG).32 2 SMS1 reaction system
2.4.3 Steady state analysis with dierent SMS concentrations
In this Subsection we want to prove mathematically that the original model (2.3), with
constant ceramide in
ux, can never be able to explain the experimental results given in
Table 2.3, especially the trends of steady states of lipid levels in response to a variation
of the value of the input u, which represents the activity of the enzyme SMS1. Instead
the second modied model (2.6) in principle can explain the experimental ndings for
particular values of some parameters.
To prove these facts it is sucient to consider the dierential equations of the two ODE
models at the equilibrium, and make some elementary considerations. Moreover these
theoretical results are independent of the choice of the particular form for the 
uxes of
the two forward and backward enzymatic reactions, and can be proven employing, instead
of the Michaelis-Menten terms considered in the two models (2.3) and (2.6), two generic

uxes v1(u;x1;PC) and v2(u;x2;x3), in both ODE systems.
These analytical results will be conrmed also by the simulated results that follow the
estimation of parameters with the methods of maximum likelihood and of sampling, de-
scribed in the next Chapters 3 and 4.
Theorem 2.4.1:
Given the ODE model (2.3), of the form _ x = f(x;), where all fi(x;) are continuous in
x 2 R3
+; 8i = 1;2;3, and assuming that the hypotheses of the Implicit function theorem
are satised, there exist the following relations between the partial derivatives of the three
states x1;x2 and x3 at equilibrium w.r.t. the input u:
@ x1(u)
@u
=  
d2
d1

@ x2(u)
@u
(2.7a)
@ x3(u)
@u
=
d2
d3

@ x2(u)
@u
: (2.7b)
This means that the variation of  x1(u) when u is varied, has always opposite sign compared
to the corresponding variations of the other two steady states  x2 and  x3.2.4 Analysis of the ODE system 33
Theorem 2.4.2:
Given the ODE model (2.6), of the form _ x = f(x;), where all fi(x;) are continuous in
x 2 R3
+; 8i = 1;2;3, and assuming that the hypotheses of the Implicit function theorem
are satised, there exist the following relations between the partial derivatives of the three
states x1;x2 and x3 at equilibrium w.r.t. the input u:
@ x1(u)
@u
=
1
d1
 (a   d2) 
@ x2(u)
@u
(2.8a)
@ x3(u)
@u
=
d2
d3

@ x2(u)
@u
: (2.8b)
This means that, if a > d2, the variation of  x1(u) when u is varied has the same sign as the
corresponding variations of the other two steady states  x2 and  x3, and so the three partial
derivatives @ xi=@u all have the same sign.
Now we prove both theorems together, since the procedure is the same.
Proof. To apply the Implicit function theorem (IFT) we consider that for both dynamical
models:
f : R
3
+  R
8
+ ! R
3
+ 2 C
1 : (x 2 R
3
+; 2 R
8
+) 7! x 2 R
3
+: (2.9)
If the hypotheses of the IFT are satised, it follows that there exist neighbourhoods U(0) 
R8
+ and V ( x(0) :=  x0)  R3
+ and a unique and smooth function  x : U ! V :  7!  x(),
that represents the steady state of the system as a continuous function of parameters. For
this reason we can consider the partial derivative of every variable at steady state  xi()
w.r.t. the parameter u, the input of the model.
If we consider the rst model (2.3) at steady state we obtain:
0 = Cin   d1   x1   v1(u;x1;PC) + v2(u;x2;x3)
0 =  d2   x2 + v1(u;x1;PC)   v2(u;x2;x3)
0 =  d3   x3 + v1(u;x1;PC)   v2(u;x2;x3):
We notice that the term v1(u;x1;PC)   v2(u;x2;x3) is the same for all three equations,
and thus we can obtain the following equalities:
Cin   d1   x1 = d2   x2 = d3   x3: (2.11)34 2 SMS1 reaction system
Considering the rst equality we obtain:
 x1 =
1
d1
 (Cin   d2   x2);
and thus if we dierentiate with respect to u, we easily obtain the relation of equation
(2.7a). If we consider the second equality instead we obtain:
 x3 =
d2
d3
 x2;
from which the second relation (2.7b) derives.
For the second modied model (2.6) one can do the same considerations just presented
above for the rst model. The model at steady state reads:
0 = a   x2   d1   x1   v1(u;x1;PC) + v2(u;x2;x3)
0 =  d2   x2 + v1(u;x1;PC)   v2(u;x2;x3)
0 =  d3   x3 + v1(u;x1;PC)   v2(u;x2;x3)
and in this case the following relations hold:
a   x2   d1   x1 = d2   x2 = d3   x3: (2.13)
As before we obtain the following relations between the steady states:
 x1 =
1
d1
 (a   d2)   x2;
 x3 =
d2
d3
 x2;
from which we derive equations (2.8a) and (2.8b). With all parameters and variables being
positive quantities, the considerations about the signs of this partial derivatives follow
easily.Chapter 3
MLE-based statistical inference
approach for parameter estimation
To describe mathematically the dynamics and the equilibrium state of the chemical reaction
of interest we presented in the previous Chapter 2 two dierent deterministic dynamical
ODE models based on chemical reaction kinetics: the rst one, given by the dierential
equations (2.3), considering a constant ceramide in
ux Cin, and the second one, model
(2.6), taking into account a positive feedback regulation between the level of DAG and the
in
ux of ceramide at the TGN.
As already underlined both systems have the same number of parameters, represented
compactly by the vector , whose values have to be estimated with particular techniques,
in order to explain the considered experimental dataset and to respect some criteria of
optimality and goodness of t.
The main content of this Chapter is the description of the results obtained for both
ODE models using a particular statistical method for the estimation of parameters, the
Maximum Likelihood Estimation (MLE). This statistical approach provides a specic value
for the parameter vector ^ MLE as result of an optimization problem. A comparison of the
results of the simulations obtained for the two ODE models with the estimated parameter
value conrms the analytical result of Section 2.4 that asserts that the feedback term is
necessary to explain qualitatively the experimental ndings of Section 2.3.
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3.1 Maximum likelihood parameter estimation
As rst topic of this Chapter we want to present a brief overview of the concept of maximum
likelihood estimation of parameters, introducing both the formal statistical denition and
the practical optimization problem that has to be implemented, describing some related
questions and problems that arise in the search of the optimal solution.
3.1.1 Statistical denition
We want to present here only the basic concepts and denitions concerning the statistical
method of maximum likelihood for parameter estimation. For further and more specic
details about the theory we refer to standard statistical texts, such as [35].
Suppose that we have a random vector y 2 Rq distributed with unknown probability
density function that belongs to the parameterized family fpy(yj); 2 g. We consider
the observation yi 2 Rn, i = 1;:::;N, where n is the number of measured outputs, and i
representing the index of the N observed experiments. In this way we set q = n  N, and
the vector y is simply the sequence of all observations yi.
The likelihood function of the set of observations y0 = fyi; i = 1;:::;Ng 2 Rq is the
function Ly0 :  ! R+ dened by:
Ly0() = py(y0j): (3.1)
The \maximum likelihood principle", introduced by Gauss in 1856 and subsequently
popularized by R.A. Fisher, suggests to take as estimate of , referring to the observed
data y0, the vector ^  2  that maximizes Ly0():
Ly0(^ MLE) = max
2
Ly0(); (3.2)
that means:
^ MLE = argmax
2
Ly0(); (3.3)
assuming implicitly that the maximum exists. In this way the value of the vector ^ MLE is
the one that maximizes the probability to see \a posteriori" the observation y0.3.1 Maximum likelihood parameter estimation 37
3.1.2 Prior distribution over parameters
As concerns the practical resolution of this optimization problem the main question that
arises is where the solution ^ MLE has to be searched in the parameter space. In a general
framework we expect that the desired result should be a global one, but most of the times
nding the global maximum is a very dicult and complex problem. This occurs especially
if the dimension p of the given parameter vector  is large and in some cases if the likelihood
function is a very irregular function, with many local maxima and minima or with stiness
properties.
Moreover in a biological framework the considered parameters represent reaction rate
constants, specic 
uxes of concentrations of reactants or other particular parameters, like
for example the Michaelis-Menten parameter. Therefore estimated parameter values should
be compatible with their biological meaning, e.g. half-lives, synthesis rates, diusion rates,
and a partial knowledge of the biochemical context under study can be useful to set some
constraints for parameters, e.g. at least positivity.
For these reasons to implement the optimization problem of interest the solution can
not be easily searched in the entire space Rp and we need constraints for our problem. In
this sense we need to impose bounds for each parameter that has to be estimated, and
it would be reasonable to set these bounds in a region where we expect that the solution
should lie.
This can be interpreted as an a priori information about the distribution of parameters,
and in a statistical framework this information can be expressed by a probability density
function (pdf) p(), that represents the a priori knowledge about  before having seen the
data y, and for this reason it is dened prior distribution over parameters.
From a practical point of view imposing bounds on parameters is a useful strategy for
ensuring convergence of MLE optimization algorithms by avoiding, during intermediate
optimization steps, inadmissible parameter values, e.g. negative values under positivity
constraints, that may either hinder recovery to the admissible parameter region or even
cause failure of numerical algorithms such as integration procedures. In a probabilistic38 3 MLE-based statistical inference approach for parameter estimation
context, imposing hard bounds on parameters by means of lower and upper limits, e.g.
min    max, can be interpreted as assuming a uniform prior distribution on parame-
ters, i.e.   U(min;max). If the parameter bounds are wide enough that the maximum of
the likelihood function is attained inside the admissible parameter region then the bounds
are not in
uential and the MLE estimate coincides with the maximum a posteriori (MAP)
estimate, i.e. the parameter value that maximizes the posterior distribution of the param-
eters given the data, under the assumption of a uniform prior. This links the MLE and
the Bayesian inference considered in the next Chapter.
As last consideration, we underline the fact that building quantitative dynamic models
for intracellular processes is only possible for specic parts of a cell, for which we have
to assume that they function autonomously and can be described in isolation. Anyway
external manipulations made on the specic subsystem do not act only locally but have
certainly multiple eects on other parts spread all over the cell. These eects could involve
unmodeled components that are not considered in the simplied model, and there could
be unexpected results that cannot be explained by the model under study [41].
It is clear how choosing model constraints and bounds for parameters has a very impor-
tant meaning and at the same time it consists in a very dicult task in the construction
of predictive models.
3.1.3 Constrained nonlinear optimization problem
As described above, the computation of the maximum likelihood estimate for the parameter
 consists, from a practical point of view, in a local optimization problem, being the solution
searched in a subspace of the parameter space Rp.
The choice of the bounds for each parameter is the rst eective problem to be consid-
ered by the computational algorithm that solves the MLE problem, dening the knowledge
about the prior distribution.
Another practical problem of the algorithm is the search of the optimum itself, i.e. the
value of the parameter that maximizes the likelihood function in the considered space.3.2 Statistical model 39
In particular, if a maximum exists, it could be not unique, or there could be many local
maxima inside the constrained subspace and the algorithm could converge to a wrong
solution.
Finally an important problem that has to be considered in the eld of the estimation of
parameters is the one of the structural identiability of parameters. In a very simple way
we can dene the probability parameterized family py(yj), or the parameter  itself, to
be locally identiable in 0, if there exists an opened region 0 around 0 where py(yj1) =
py(yj2) implies 1 = 2; 81;2 2 0 [35]. It means that a parameter is not identiable if
the probability to see the data given the parameter, i.e. the likelihood function, takes the
same value for two dierent parameter vectors. Written in a mathematical way if:
Ly(1) = Ly(2); 1 6= 2: (3.4)
3.2 Statistical model
The computation of the likelihood function Ly(), where y is the given dataset, and the
consequent possibility to estimate a specic set of parameters that maximizes it, require
obviously to dene the likelihood function itself, i.e. to introduce the statistical model that
will be considered for the simulations and the estimation problem.
We report now the rst considered deterministic model, represented by the ordinary
dierential equation system (2.3) for the lipid concentrations, introducing also the outputs
zi that we used in our simulations with Matlab. We dene them as the natural logarithm
of the three state variables (see equations (3.6)), and the reason of this choice has to do
with the form of the statistical model that will be explained just afterwards. The equations
of the model and of the outputs are:
_ x1 = Cin   d1  x1   p1 u
x1  PC
x1  PC + k1
+ p2 u
x2  x3
x2  x3 + k2
_ x2 =  d2  x2 + p1 u
x1  PC
x1  PC + k1
  p2 u
x2  x3
x2  x3 + k2
_ x3 =  d3  x3 + p1 u
x1  PC
x1  PC + k1
  p2 u
x2  x3
x2  x3 + k240 3 MLE-based statistical inference approach for parameter estimation
z1 = logx1 (3.6a)
z2 = logx2 (3.6b)
z3 = logx3: (3.6c)
The same output equations apply also to the second ODE model (2.6), which diers only
by parameter Cin being replaced with the term a  x2.
To introduce the chosen statistical model, we assume that the observed data, that are
the three steady state lipid concentrations for the three dierent experimental conditions,
dened as  yi;u, are given by the steady state concentrations predicted by the model as
function of the parameter  multiplied by the errors i;u. The index i represents the three
dierent state variables x1, x2 and x3 of the ODE systems, i.e. the normalized concentra-
tions of ceramide, diacylglycerol and sphingomyelin, while u represents the dierent values
of the input for the three dierent experimental conditions, control, overexpression and
silencing, respectively. The equations for the measurements are:
 yi;u =  xi;u()  i;u i = 1;2;3; u = 1;2:2;0:77: (3.7)
The choice of this particular relation between data and measurement errors arises from
the fact that biological concentration measurements are strictly nonnegative, such that
an additive measurement noise model may not adequately describe experimental data.
Moreover measurement errors increase often with the measure itself, as with the constant
coecient of variation model in which (additive) measurement noise has a standard devi-
ation proportional to the measure, e.g. y = x+x = x(1+) with  zero mean random
noise with standard deviation equal to the coecient of variation. A convenient proba-
bilistic representation of measurements that combines both nonnegativity and increase of
noise with measurement levels, is given by the log-normal distribution, described in the
next Subsection.
As already presented in the equations (3.6) after the ODE model above, we dene the
outputs of the model to be the natural logarithm of the state variables, and this relation3.2 Statistical model 41
is valid in particular for the equilibrium situation:
z() = log(x()) ()  z() = log( x()): (3.8)
3.2.1 Log-normal distribution error model
The properties of the stochastic model are determined in our case by the denition of the
statistical error model, i.e. the distribution of the measurement errors i;u, for each vari-
able and experimental condition. For our simulations we chose a log-normally distributed
measurement noise.
In probability theory, a log-normal distribution is a continuous probability distribution
of a random variable whose natural logarithm is normally distributed. It means that if
Y is a log-normally distributed random variable, then X = log(Y) has a normal distribu-
tion. The log-normal distribution is a distribution of a random variable that assumes only
positive real values, [12, pp.578] and [29].
In our study it means that the natural logarithm of the errors i;u is normally dis-
tributed, and we can summarize this fact with the following equation:
i;u  logN(0;
2
i;u) () log(i;u)  N(0;
2
i;u): (3.9)
The normal distribution at the right side is characterized by mean zero and variance 2
i;u.
The values of the standard deviations i;u that we considered in our simulations are the
ones listed in Table 2.3 together with the observed data  yi;u, that had been normalized
w.r.t. the control values.
If we consider equation (3.7), that expresses the observed data as function of the sim-
ulated state variables and of the measurement noise, and we take the natural logarithm of
both sides we obtain the relation:
~ yi;u = log( yi;u) = log( xi;u()) + log(i;u) =  zi;u() + log(i;u): (3.10)
In this way we obtain a linear relation between the logarithm of the data ~ yi;u, the outputs
of our model at steady state  zi;u() and the logarithm of the errors. This relation allows42 3 MLE-based statistical inference approach for parameter estimation
us to nd a specic expression of our stochastic model, given by the probability density
function p(yj), i.e. the likelihood function, that describes the stochastic data generation
process given the parameters of the model .
In fact from the equations (3.9) and (3.10) we derive that also the natural logarithm of
data is normally distributed, with mean  zi;u() and same variance of the errors 2
i;u:
~ yi;u  N( zi;u();
2
i;u): (3.11)
Assuming all measurement errors to be independent and log-normally distributed, as de-
ned in equation (3.9), we obtain the following expression for the likelihood function:
L~ y() = p(~ yj) =
Y
u;i
p(~ yi;uj) =
Y
u;i
1
i;u
p
2
exp
"
 
1
2

~ yi;u    zi;u()
i;u
2#
: (3.12)
We underline again the fact that the considered distribution is relative to the logarithm
of the dataset, otherwise we should have used in (3.12) the expression of the pdf of a log-
normal distribution, but in general the normal distribution has a lot of more interesting
properties and we prefer to consider the given expression (3.12).
3.3 Simulations and results on simulated data
In this Section we report some details about the simulations concerning the maximum
likelihood parameter estimation (MLE), and the results relative to both ODE systems
(2.3) and (2.6) without and with the feedback regulation term. This analysis regarding
the MLE was carried out mainly to investigate a rst model t for both ODE systems,
to check the hypothesis of the feedback control eect and to determine the prior support
region of the parameters to be used also for the sampling analysis that will be described
in the next Chapter 4.
All simulations were carried out with the numerical computing environment Matlab,
with the additional utilization of the toolboxes Sbpd, Sbtoolbox2 , which oer specif-
ically a powerful environment in which to build models of biological systems, and nally
Mcmcstat. This last toolbox was used exclusively for the simulations described in the3.3 Simulations and results on simulated data 43
next Chapter 4 to carry out the sampling from the posterior distribution with a Markov
Chain Monte Carlo method.
For more information all specic details about the program and the code written in
Matlab are reported in the Appendix A.
3.3.1 Estimation of parameters in logarithmic scale
For all simulations concerning the estimation of parameters, we applied a logarithmic
transformation to base 10 to the parameter vector, so that the objective function Ly(),
that was originally function of the vector , becomes function of the new vector   = log10 .
This means formally that  in the dynamic models is replaced by 10log10  = 10 . Practically
in the two ODE systems we dened the previous parameter vectors, 1 for the rst model
and 2 for the second one, to equal:
1 = 10
 1 = (Cin;p1;p2;d1;d2;d3;k1;k2) (3.13a)
2 = 10
 2 = (a;p1;p2;d1;d2;d3;k1;k2) (3.13b)
so that the new parameters to estimate are:
 1 = log10 1 (3.14a)
 2 = log10 2: (3.14b)
If we dene as ^  the estimated solution of the optimization problem (without active con-
straints):
^  = argmax

Ly() (3.15)
then the following optimality condition holds:
rLy()j=^  = 0: (3.16)
If we suppose that ^  > 0, then we can state that the optimal solution does not change with
the logarithmic transformation, obtaining:
^   = ^ log10  = log10 ^  = argmax
log10 
Ly(10
log10 ): (3.17)44 3 MLE-based statistical inference approach for parameter estimation
In fact with the logarithmic transformation the condition of positivity of (3.15) is fullled
and, moreover, the following optimality condition for the new estimated parameter vector
(3.17) holds:
rlog10 Ly(10
log10 )


log10 = ^ log10  = log10  diag()rLy()j=^  = 0 (3.18)
where
diag()rLy() = [1
@Ly()
@1
;2
@Ly()
@2
;:::]
T (3.19)
being i = 10log10 i. We can notice in particular that, with the considered transformation,
the two optimality conditions (3.16) and (3.18) are equivalent, holding ^  > 0.
In this way the elements of the gradient (3.18) are given by:
@Ly(10log10 )
@log10 i
= log10 
@Ly()
@i
i = log10 
@Ly()
@i=i
(3.20)
and in principle the logarithmic transformation of parameters causes the only fact that the
derivative of the objective function Ly() with respect to the components of the vector 
becomes scaled by the value of the corresponding component and in some way it is replaced
by the derivative of Ly() w.r.t. relative changes of parameters.
Such non-linear transformation of parameters has a positive eect on the properties of
convergence of the optimization algorithm towards the optimum (maximum or minimum)
solution, because it reduces the problems with parameter scaling, especially if the nal
parameter values are very distant from the initial conditions of the algorithm. At the same
time the transformation into logarithmic scale implicitly guarantees the constraint that all
parameters remain positive.
The details of how these transformations were implemented in the model in the Matlab
code are reported in Appendix A.
In the next subsection we will explain the choice of the prior distribution of parameters
p( ) = p(log10 ), and we will assume a log-uniform prior distribution for the model param-
eter , i.e. the log-transformed random variable   is assumed to be uniformly distributed.3.3 Simulations and results on simulated data 45
3.3.2 Choice of bounds for parameters
To solve with Matlab the constrained optimization problem of determining a maximum
likelihood estimate ^ MLE for the parameter vector , we employed the Matlab function
fmincon which attempts to nd a constrained minimum of a scalar multivariable function
starting at an initial estimate.
As optimization algorithm was chosen OPTIONSfmincon.Algorithm='interior-point',
the tolerance on the constraint violation and the termination tolerance on the function value
were set to OPTIONSfmincon.TolCon = 1e-6 and OPTIONSfmincon.TolFun = 1e-6. The
objective function given as input to the optimization algorithm was minus the logarithm of
the likelihood function, i.e.  logL~ y(), having to nd the maximum of the likelihood, and
since the logarithm does not change the optimal solution being a monotonically increasing
function.
The main issue of this analysis was the choice of the constraints for the 8 parameters
that had to be estimated. In fact we had no information at all about some possible values
of the constant rates coming from biological knowledge and we had even no indicative
awareness about the order of magnitude of such parameters. In the statistical framework
this means that there wasn't any knowledge about the prior distribution of parameters.
In order to nd the optimal solution, we made multiple attempts to detect where (in the
parameter space) the objective function assumed larger values. Some useful information
during these trials was given by the fact that, for some of the 8 parameters, the nal
values were at one of the edges imposed by the constraints on the parameters. Thus in
the following attempts the specic bounds were expanded or moved to the right or left
direction in accordance with where the previous respective values had been estimated.
We decided to choose a width of the intervals of all parameters of 4 units, that in a
logarithmic scale is equivalent to four orders or magnitude. Since we had no information
about those values a priori, as already explained, we consider it a reasonable choice to start
with. After multiple attempts to nd a good estimate of the parameter ^  MLE, we set the
intervals to be approximately symmetric around the nal values. These bounds will be46 3 MLE-based statistical inference approach for parameter estimation
kept xed also for the simulations concerning the sampling from the posterior distribution,
described in Chapter 4. This procedure is a sort of empirical Bayes method, in which the
prior distribution is estimated from the data. Of course the boundaries relative to two
ODE systems resulted very dierent for almost the totality of all 8 parameters. All the
details and specic results will be explained in the two next Subsections, for the model
without and with feedback term, respectively.
3.3.3 Model without feedback
As rst point of our simulations, we carried out the maximum likelihood estimation for
the rst model, given by the dierential equation system (2.3), with outputs (3.6). We
underline again the fact that in the implementation with Matlab we eectively dened
the parameters in logarithmic scale, as dened in equation (3.14). After many attempts to
dene the bounds for each parameter i 2 R8
+, we determined boundaries for each  i 2 R8
that cover intervals of four units around the MLE parameters ^  MLE, that, considering the
real model parameter  = 10 , are equivalent to intervals of four orders of magnitude.
We calculated a specic set of values dening the maximum likelihood estimate ^  MLE =
log10 ^ MLE by maximization of the likelihood function L~ y( ) = L~ y(log10 ).
In Table 3.1 are reported the MLE values of the parameters and the respective bounds
that dene the support region of the log-uniform prior distribution. The log likelihood
value calculated for this specic maximum likelihood estimate, which is a measure of the
overall data t quality, is logL~ y(^ MLE) = 7:3.
Afterwards we simulated the rst ODE model (2.3) with the specic parameter values
reported in Table 3.1 (to be more precise ^ MLE = 10
^  MLE), considering especially the
equilibrium situation. The main interest is to compare the experimental dataset with the
steady state lipid concentrations predicted by the particular dierential equations model
_ x = f1(x; ^ MLE).3.3 Simulations and results on simulated data 47
Table 3.1: MLE parameters for the rst ODE model (2.3) without feedback and respective
prior support regions.
Parameter ^   ^  MLE Prior support region
log10 ^ Cin 3.1015 [1,5]
log10 ^ p1 -1.9265 [-4,0]
log10 ^ p2 1.3463 [-1,3]
log10 ^ d1 3.0591 [1,5]
log10 ^ d2 -2.0617 [-4,0]
log10 ^ d3 -2.0513 [-4,0]
log10 ^ k1 -4.0847 [-6,-2]
log10 ^ k2 3.7859 [2,6]
In Figure 3.1 we can see the simulated trajectories of the lipid concentrations for ce-
ramide, DAG and SM. Starting from random initial conditions, the model _ x = f1(x; ^ MLE)
was simulated for the three dierent experimental conditions, i.e. for the three dierent
values of the input u = 1;2:2;0:7, that are represented in the rst, second and third panels
of Figure 3.1, respectively. We can at rst notice how the simulated trajectories, and con-
sequently the steady states, of ceramide remain always constant for all three experimental
conditions, as though the SMS1 activity manipulations, obtained through overexpression
and silencing, had no eect on the concentration of this lipid. As already mentioned,
and even mathematically proved at the end of Section 2.4, we arm that the considered
ODE model is not able to t the qualitative changes of the steady state levels of ceramide
in response to the alteration of the activity of the enzyme, and for this reason the pre-
dicted steady state concentration is simply the mean between all measurements, because
the model prediction in response to SMS1 manipulation would have an opposite behaviour
respect to the eective trend of data. Instead the simulated steady states of DAG and
SM appear to be more sensitive to the changes of the amount of SMS1, signicantly in-
creasing and decreasing w.r.t. the control level in the cases of overexpression and silencing,
respectively.48 3 MLE-based statistical inference approach for parameter estimation
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Figure 3.1: Trajectories of lipid concentrations obtained with the ODE model with constant
ceramide in
ux Cin simulated with the MLE parameters of Table 3.1, plotted together with
the experimental data at steady state for the three dierent experimental conditions.
These results are reached by a high turnover rate for ceramide in comparison to its
conversion in the SMS1 driven enzymatic reaction, i.e. ceramide has a high production
( ^ Cin ' 1:26  103) and high degradation rate (^ d1 ' 1:15  103) compared to the forward
rate constant for the reversible reaction (^ p1 ' 1:1810 2). SMS1 manipulations thus eect
ceramide steady state levels only marginally. On the other side the degradation rates of3.3 Simulations and results on simulated data 49
DAG and SM are almost the same (^ d2 ' 0:87  10 2; ^ d3 ' 0:89  10 2) and much slower
that the one of ceramide. We can also notice that these last two parameters are of the
same order of magnitude as the forward rate constant of the reversible reaction, and for
this reason their steady state levels can be highly regulated by the activity of SMS1. The
two Michaelis-Menten constants dier in several orders of magnitude (^ k1 ' 8:23  10 5
and ^ k2 ' 6:11  103) but we can maintain that the estimates of these parameters are not
reliable, since the model does not depend linearly on them, and thus we do not pay too
much attention on the signicance of these values [41].
We can notice that the concentrations of DAG at steady state, predicted by the model
for this particular MLE parameter vector, are always slightly higher than the SM level for all
experimental conditions. The experimental data instead show a dierent behaviour, with
DAG slightly above SM in the overexpression experiment, and on the contrary slightly
beneath SM in the silencing experiment. Since the same amounts of DAG and SM are
produced or consumed by the enzymatic reversible reaction, and moreover there is no
signicant dierence in the estimated degradation rate constants d2 and d3, the model
cannot explain at the same time both eects just presented and the trend of the increase
and decrease for a single reactant is the same for all experiments. Anyway the experimental
data of DAG and SM are still well captured by the model.
3.3.4 Model with feedback
We report now the same kind of results described in the previous Subsection obtained
this time for the second ODE model (2.6) that takes into account the positive feedback
regulation from the concentration of DAG on the in
ux of ceramide at the TGN.
In the implemented dierential equation for the concentration of ceramide, with all
parameters expressed in logarithmic scale, the constant term 10log10 Cin is replaced by the
term 10log10 a  x2.
Table 3.2 reports the MLE values for all 8 parameters, and the respective bounds, that
dene the support regions for the log uniform prior distributions. The 8 real estimated50 3 MLE-based statistical inference approach for parameter estimation
model parameters are given by ^ MLE = 10
^  MLE. The log likelihood value calculated for this
specic maximum likelihood estimate is in this case logL~ y(^ MLE) = 14:3, which is twice
the one obtained for the rst model (2.3). This result is already an interesting information
about the fact that the second modied model can better t the given dataset.
Table 3.2: MLE parameters for the second ODE model (2.6) with feedback and respective
prior support regions.
Parameter ^   ^  MLE Prior support region
log10 ^ a 2.9391 [1,5]
log10 ^ p1 1.5896 [0,4]
log10 ^ p2 3.4195 [1,5]
log10 ^ d1 2.9116 [1,5]
log10 ^ d2 1.0208 [-1,3]
log10 ^ d3 1.0302 [-1,3]
log10 ^ k1 0.0974 [-3,1]
log10 ^ k2 2.5266 [0,4]
One can immediately notice that the maximum likelihood estimates are in this case
very dierent from those obtained in the rst model, reported in Table 3.1, and thus also
all prior support intervals. While the synthesis and degradation rates of ceramide are of the
same order of magnitude than before (^ a ' 0:87103 and ^ d1 ' 0:82103), the SMS1 driven
forward and backward reaction rate constants p1 and p2 are several orders of magnitude
larger in this second model (^ p1 ' 0:39  102 and ^ p2 ' 2:63  103). As a consequence the
ceramide level at equilibrium is much more in
uenced by manipulations of the input u than
with the rst model. Also the degradation rate constants of DAG and SM are larger than
before but always very similar (^ d2 ' 0:1102 and ^ d3 ' 0:11102) and nally the Michaelis-
Menten constants are dierent in the modied model (^ k1 ' 1:25 and ^ k2 ' 3:36  102)
[41].3.3 Simulations and results on simulated data 51
To see eectively the change of the quality of the data t for this second revised model,
we simulated it with the estimated set of parameter values of Table 3.2. The resulting
trajectories for the three lipid concentrations in the three dierent experimental conditions
are shown in Figure 3.2.
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Figure 3.2: Trajectories of lipid concentrations obtained with the second ODE model with
the feedback regulation simulated with the MLE parameters of Table 3.2, plotted together
with the experimental data at steady state for the three dierent experimental conditions.52 3 MLE-based statistical inference approach for parameter estimation
One can immediately observe that in this case the steady state ceramide levels predicted
by this second model can qualitatively follow the real trend of the experimental data in
response to manipulations of the input u. As before the steady state level of DAG is always
above the level of SM for all three experiments, observing only the experimental nding
relative to the overexpression experiment, and not the one of silencing. The explanation is
the same of that described for the rst ODE model.
3.3.5 Comparison of the results of the two models
The results obtained with the simulations of the two ODE models (2.3) and (2.6) for
the particular values of the parameter vectors estimated with the method of maximum
likelihood estimation ^ MLE = 10
^  MLE conrm the theoretical investigations of the steady
state analysis, described in Section 2.4, and moreover showed a good t quality.
Since the qualitative behaviour of ceramide steady state levels cannot be captured by
the rst model (2.3) in all three experiments, the most likely parameters are those that
leave ceramide levels constant across all three experiments, as can be seen in Figure 3.1.
Instead, with the introduction of the hypothesis of the feedback regulation from DAG
to ceramide, the second model (2.6) is able to qualitatively capture the changes of ceramide
endogenous levels in response to SMS1 manipulation.
Besides this fundamental outcome, that corroborates our biological hypothesis and also
our formal mathematical results, these statistical simulations were interesting to detect
the prior support regions of the parameter distribution, that will be used for the Bayesian
estimation approach of the sampling from the posterior distribution described in the next
Chapter. Considering intervals of four orders of magnitude we maintain that in this way
we can evaluate a wide range of possible values for parameters and this is also interesting
for the reason that we do not have any a priori information about the values of such
parameters.Chapter 4
Sampling-based Bayesian approach
for parameter estimation
In addition to the statistical inference approach of MLE presented in the previous Chapter,
we used also another method for parameter estimation, that consists in a sampling-based
statistical Bayesian approach.
This technique for parameter estimation has the big advantage that it provides not
only best point estimates (e.g. MAP: maximum a posteriori probability estimation) but
also the entire a posteriori distribution of parameters, allowing the assessment of condence
intervals for parameters and of model predictions.
In this Chapter we will present a general overview of the idea of Bayesian learning, in-
troducing the concept of sampling from the posterior distribution, and a particular method
to realize it: the Metropolis-Hastings algorithm from the class of the Markov chain Monte
Carlo sampling methods. We applied this statistical technique to the two considered ODE
parametric models (2.3) and (2.6) to carry out the parameter estimation, and also in this
case we found that the model with feedback can t the experimental data in the right way,
while this does not hold for the rst ODE model with constant ceramide in
ux.
Besides the results concerning the data t, we will present also interesting information
about the predictions of the two models and about the marginal posterior distributions,
quantities that supply a rst understanding of the distribution and the identication of
the single parameters.
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4.1 Introduction: Bayesian learning
In this introductory Section we want to present the basic general concepts of the statistical
method of Bayesian learning. For more details about the theory we refer to standard books
such as [12, 43].
In general statistical inference is concerned with drawing conclusions about unobserved
quantities starting from the knowledge of experimental numerical data.
In particular Bayesian inference is the process of tting a stochastic model to a dataset
and summarizing the result by a probability distribution on the model parameters  and
on unobserved quantities, such as predictions for new observations z [12, Chap. 1].
These probability models that characterize Bayesian conclusions about the quantities
of interest,  and z, are conditional on the observed data y. This feature of conditioning
on observed data distinguishes Bayesian inference from common approaches to statistical
inference that aim to estimate  (or z) over the distribution of possible y values conditional
on the true unknown value of , as in the case of the maximum likelihood estimation (MLE).
In a Bayesian framework we need stochastic models for quantities that we observe and
for quantities about we wish to learn. Data y and parameter  are interpreted as random
variables, with respective probability density functions often referred to as data distribution
(or sampling distribution) p(yj) and prior distribution p(). These two densities describe
the stochastic data generation process given model parameter  and the a priori knowledge
about  itself before having observed the data. For given , p(yj) is a probability distri-
bution over all possible observations y. Instead for given data y, and as a function of the
unknown parameter , it expresses how probable it is to observe the data for each value of
the model parameter, and in this context it is called the likelihood function p(yj) = Ly(),
as described in Section 3.1.
In this way we can obtain a model providing the joint probability distribution for  and
y, whose density function is given by the product of the two previous densities:
p(;y) = p()  p(yj) = p()  Ly(): (4.1)4.1 Introduction: Bayesian learning 55
4.1.1 Posterior distribution
The main function of interest in a Bayesian framework is the posterior distribution, which
is the distribution over the parameter  conditioned on the observed value of the data y.
By applying the basic property of conditional probability known as Bayes' rule, we obtain
the following expression for the posterior density function:
p(jy) =
p()  Ly()
p(y)
; (4.2)
where p(y) is the marginal likelihood given by:
p(y) =
Z
p(yj)p()d: (4.3)
Often one can express equation (4.2) by omitting the factor p(y), which does not depend
on  and, given xed y, can thus be considered as a constant, albeit unknown. In this way
we obtained an unnormalized posterior distribution, that reads:
p(jy) / p()  Ly(): (4.4)
This last expression of the posterior distribution will be, in particular, the starting point
for the resolving algorithm for parameter estimation, described in the following Section
4.2.
We can notice that using Bayes' rule and given a specic stochastic model, the posterior
distribution (4.4) is in
uenced by data y only through the likelihood function Ly(). In
this regard the chosen statistical model, which comprises the deterministic structure of the
system and the stochastic nature of parameters and measurement errors, plays a funda-
mental role in the analysis of experimental data and determines results and conclusions
[12, Chap. 1].
4.1.2 Model prediction
In a Bayesian learning approach also unknown observable quantities are often important
objects of interest, like in the case of predictions for new outputs of the model that have
not yet been observed.56 4 Sampling-based Bayesian approach for parameter estimation
Following a similar logic like the one used to obtain the posterior distribution, we can
introduce the density function of the unknown but observable data y as:
p(y) =
Z
p(y;)d =
Z
p()p(yj)d =
Z
p()Ly()d: (4.5)
Previously we had dened this quantity as marginal distribution of y, but a more in-
formative name is prior predictive distribution, indicating that it is a distribution over an
unknown observable quantity (prediction) that is not conditional on previous observations.
Introducing the knowledge of the observed data y, we can predict a new unknown
observable quantity z, generated from the same process, through the denition of the
posterior predictive distribution p(zjy), posterior because it is conditional on the observed
data y, and predictive because it is a prediction for the observable z [12, Chap. 1].
4.2 Sampling from the posterior distribution
4.2.1 Monte Carlo integration
Before dealing with the concept of sampling from the posterior distribution p(jy), we want
to present the Monte Carlo method for numerical integration. The main application of this
method is the computation of complex integrals of multivariate functions, such as expected
values of the form:
Ep[f(x)] =
Z
Rn
f(x)p(x)dx x  p(x); x 2 R
n (4.6)
approximating this integral through a sample mean.
In fact, if fxt; t = 1;:::;Ng are N independent and identically distributed realizations
of the random process x, following the distribution p, then, for the strong law of large
numbers, the sample average converges almost surely towards the expected value (4.6).
Formally this reads:
Pr
 
lim
N!1
 fN(x) = lim
N!1
1
N
N X
t=1
f(xt) = Ep[f(x)]
!
= 1 (4.7)4.2 Sampling from the posterior distribution 57
where
xt  p(x) i:i:d: 8t = 1;:::;N; xt 2 R
n: (4.8)
In this way it is possible to numerically calculate multidimensional integrals that are usually
not solvable in an analytical way, because of the high dimension of the problem, and this
represents one of the most important and common issues in Bayesian statistics.
The question that arises now concerns the simulation of the samples xt from the random
distribution of interest p(x), as indicated in equation (4.8). There are particular cases
in which it is possible to sample directly from the desired density function, e.g. from
uniform or normal distributions. If the direct sampling from p(x) is not possible (or not
computationally ecient), we have to consider other strategies, like the Markov chain
Monte Carlo methods, described in the next Subsection, which use computer simulation
of Markov chains in the parameter space.
4.2.2 Markov chain Monte Carlo methods: MCMC
Markov chain Monte Carlo (MCMC) methods are a class of algorithms for sampling from
probability distributions based on constructing a Markov chain whose equilibrium distri-
bution is the desired one. In a Bayesian approach the Markov chain is dened in such a
way that the posterior distribution p(jy), in the given statistical inference problem, is the
asymptotic distribution, and each state of the chain represents a sample of the parameter
vector, named k. The samples are drawn iteratively from approximate distributions, with
the distribution of the sampled k given all previous drawn values depending only on the
last drawn value k 1. Hence they represent draws form a Markov chain, but lose the
property of independence between them. The key to the method's success, however, is not
the Markovian property but rather the fact that, under suitable hypotheses, the gener-
ated chain fkg has as asymptotic distribution the target posterior distribution p(jy) [12,
Chap. 11].58 4 Sampling-based Bayesian approach for parameter estimation
This allows to use ergodic sample averages:
^ J =  fNs() =
1
Ns
Ns X
k=1
f(k) k  p(jy); k 2 R
p (4.9)
to approximate desired posterior expectations:
J = E[f()] =
Z
Rp
f()p(jy)d   p(jy);  2 R
p (4.10)
as described in the previous Subsection. In fact in a Bayesian framework the posterior
distribution p(jy) contains all relevant information on the unknown parameter  given the
observed data y, and all statistical inference can be deduced from the posterior distribution,
typically by evaluating integrals of the form (4.10). For example, point estimate for the
parameter can be given by the posterior mean, i.e. f() = , or prediction for unobserved
data z is based on the posterior predictive distribution p(zjy) =
R
p(z;jy)d, for which
we obtain f() = p(zj) (see also equation (4.18) in Section 4.4). Another quantity of
interest could be the marginal posterior distribution for each single parameter composing
the vector  2 Rp:
p(ijy) =
Z
:::
Z
p(jy)d1:::di 1di+1:::dp; (4.11)
that can be calculated by means of Monte Carlo estimation too.
Hence the art of MCMC simulation is to set up a Markov process whose stationary
distribution is the desired posterior p(jy), and run the simulation long enough that the
distribution of the current draws is close enough to this stationary distribution. Practi-
cally one cannot however prove convergence, but only diagnose a negative result on non
convergence [12, Chap. 11] and [31].
Several standard approaches to dene such Markov chains exist, e.g. the Gibbs sampler
or the Metropolis-Hastings algorithm, which is described in the next Subsection. Using
these algorithms it is possible to implement posterior simulation in essentially any problem
which allows pointwise evaluation of the prior distribution p() and of the likelihood func-
tion Ly() [12, Chap. 11] and [31]. Once the simulation algorithm has been implemented,
and the samples generated, then it is absolutely necessary to check the convergence of the
simulated sequence [12, Chap. 11]. We discuss how to check convergence in Section 4.3.4.2 Sampling from the posterior distribution 59
4.2.3 Metropolis-Hastings (MH) algorithm
There are cases in many statistical models in which the complete conditional posterior
distributions p(jji;i 6= j;y) assume the expression of some known distributions from
which direct sampling is possible, allowing ecient random variate generation. In these
cases the Gibbs sampler represents an interesting simulation algorithm. But there are also
many important applications in which this is not the case, requiring alternative MCMC
algorithms.
The most general Markov chain simulation method is the Metropolis-Hastings (MH)
algorithm [14, 24], of which the Gibbs sampler and the Metropolis scheme [30] are special
cases. The algorithm proceeds as follows [12, Chap. 11] and [31]:
1. initialise 0, for which p(0jy) > 0, from a starting distribution p0();
2. at time k  1, generate a proposal  from some proposal distribution (or jumping
distribution) Jk(jk 1), where k 1 is the current state of the Markov chain (the
choice of the proposal distribution Jk(:) is discussed later);
3. compute the ratio
r =
p(jy)
p(k 1jy)

Jk(k 1j)
Jk(jk 1)
(4.12)
(N.B. the ratio r is always dened, since a jump from k 1 to  can only occur if
both p(k 1jy) and Jk(jk 1) are greater than zero);
4. compute the acceptance factor (k 1;) = minf1;rg and set
k =
8
> <
> :
; with probability (k 1;)
k 1; otherwise
(4.13)
5. increase k by one unit and return to point 2.60 4 Sampling-based Bayesian approach for parameter estimation
The Metropolis algorithm [30] is a special case of the MH, in which the proposal distri-
bution is a symmetric function, satisfying the condition Jk(ajb)  Jk(bja), 8a;b and
k. In this case the acceptance factor becomes:
(k 1;
) = min

1;
p(jy)
p(k 1jy)

: (4.14)
The acceptance/rejection rule of the Metropolis algorithm can be stated as follows: if the
candidate  at time k has probability p(jy) > p(k 1jy), then (k 1;) = 1, i.e. all
parameters with posterior probability greater than the one of k 1 are accepted. Otherwise
if p(jy) < p(k 1jy), then  is accepted with probability (k 1;) < 1. In this way
there can be also jumps towards regions with smaller posterior density, that otherwise
would never be explored.
Both for the basic Metropolis algorithm and for the more general Metropolis-Hastings,
some regularity conditions are requested to be able to prove the convergence of the Markov
chain to the target posterior distribution, showing rst that the simulated sequence is
a Markov chain with a unique stationary distribution and second that this stationary
distribution equals the target distribution. These properties requested for the Markov
chain are: ergodicity (which comprises the properties of irreducibility, aperiodicity and
recurrence), and reversibility respect to the distribution p(jy), that implies the property
of invariance w.r.t. the same posterior distribution.
Under these mild regularity conditions the MCMC estimator (4.9) is also proved to be
asymptotically unbiased and normally distributed.
We notice that to solve the MH algorithm it is necessary to be able to calculate the ratio
r in (4.12) for all parameters (;), and to draw a sample  from the proposal distribution
Jk(j), for all  and k. The rst point is ensured by the fact that in (4.12) we have a
ratio of the posterior distributions calculated for  and for k 1. In fact in general the
normalization factor p(y) in the equation (4.2) is extremely dicult to compute, and in
this way the presented algorithm can generate samples from p(jy) without knowing this
constant of proportionality. It requires only that a function proportional to the desired
density p(jy) be calculable, represented in this context by the product of the prior and of4.2 Sampling from the posterior distribution 61
the likelihood, as highlighted by equation (4.4). Finally step 4 requires the generation of
uniform distributed random numbers [12, Chap. 11].
The choice of the proposal distribution Jk(jk 1) is essentially arbitrary, and subject
only to some technical constraints. The ideal jumping rule would be to sample the proposal
 from the target distribution, i.e. to have J(j)  p(jy), 8. In this way the ratio r in
(4.12) is always 1, and the draws k are a sequence of independent samples from p(jy) [12,
Chap. 11]. Since usually this algorithm is applied to problems for which direct sampling
is not possible, some good properties for the proposal distribution are necessary and the
success of the MCMC methods depends in general on how well the proposal distribution
ts the target distribution. Allowing asymmetric jumping rules (in the case of MH), for
example, could be useful in increasing the speed of the random walk. Other interesting
and useful ideas to dene an ecient jumping rule are presented in [11] and in [12, Chap.
11].
In the next Subsection we present an ecient variation of the MH simulation algorithm.
4.2.4 DRAM: Delaying Rejection Adaptive Metropolis
An ecient variation of the MCMC method consists in the delaying rejection adaptive
Metropolis (called DRAM). The authors in [18] propose some strategies to combine e-
ciently two powerful ideas appeared in the literature about MCMC: adaptive Metropolis
samplers [16, 17] and delaying rejection [40].
Delaying rejection (DR) is a strategy to modify the standard MH algorithm that is
proved to outperform the original method in the Peskun absolute eciency ordering [40].
This means that, using the DR, we obtain MCMC estimators (4.9) that have a smaller
asymptotic variance for every function f, whose expectation relative to p(jy) we want to
estimate [18]. The basic idea of this method is that, upon rejection happened in a MH step,
instead of advancing time and saving the current position, a second stage move is proposed.
The probability of the second proposal to be accepted is computed so that reversibility of
the Markov chain relative to the target distribution is preserved. Such a process of delaying62 4 Sampling-based Bayesian approach for parameter estimation
rejection can be iterated for a xed or random number of stages. Moreover DR allows
partial adaptation of the proposal within each iteration of the simulation, since the higher
stage proposals can depend on the candidates so far proposed and rejected. DR can be
considered as a way of combining dierent proposals for MH: in order to better explore the
parameter space, global moves are tried rst and local moves follow later. Specic details
about the DR algorithm are given in [18].
The adaptive Metropolis (AM) algorithm can be considered as a global adaptive strategy
that in the DRAM method is combined with the local adaptive strategy provided by the
DR. The main intuition behind this method is that updating the Metropolis jumping rule
during the simulation can improve the value of the acceptance rate, i.e. the proportion of
jumps that are accepted. There are in fact some proposed optimal values for the acceptance
rate (see [11] and [12, Chap. 11]), relating to the specic proposal distribution being used,
that can be better obtained with some adaptive simulation algorithms. In particular in
the AM approach on-line tuning, that means modifying while the simulation is running,
the Metropolis proposal distribution can be based on the past history of the chain. Due to
this adaptation, the chain looses its Markovian and reversibility properties. Anyway the
authors in [17] show that, under some regularity conditions on the adaptation scheme of
the proposal, the AM preserves the desired stationary distribution [18]. More details and
theory about the implementation of this method are presented in [16, 17, 18].
The intuition behind adaptive strategies is to learn from the information obtained
during the simulation, and to tune the proposal to work in a more ecient way. There are
in general plenty of strategies of combining AM or MH together with the DR approach, as
highlighted in [18]. The authors show how a successful combination of the two algorithms,
that modify the standard MH sampler, outperforms the original simple methods: the
adaptation AM enhances the eciency of the delaying rejection algorithm in cases where
good candidates for the proposal distributions are not available. On the other hand the
DR provides a systematic remedy for cases where the adaptation has diculties to get
started [18]. In their work the authors also prove the ergodicity of the combined approach
and demonstrate with some test examples the eciency of the method.4.3 Convergence test 63
4.3 Convergence test
As already mentioned, the use of the MCMC estimator (4.9) requires the verication
of two conditions related to convergence. First of all, the Markov chain has to converge
asymptotically, i.e. for Ns ! 1, to the desired posterior distribution p(jy). Second, even if
this theoretical convergence is established, we need a convergence test to assess when to stop
simulations in the practical implementation of the algorithm. The regularity conditions
necessary to ensure the convergence to the target posterior distribution, mentioned also
in Section 4.2 in the description of the MH algorithm, are: ergodicity, which includes
irreducibility, aperiodicity and recurrence, and invariance, for which reversibility represents
a sucient condition. These properties have to be veried in the implementation of Gibbs
or MH algorithms, especially when choosing the proposal distribution.
Practically more important than establishing theoretical convergence, is to recognize
practical convergence. In fact a critical issue when using MCMC methods is how to deter-
mine when it is safe to stop sampling and use the samples to estimate characteristics of the
distribution of interest. Practically we have to judge when suciently many transitions Ns
have been simulated to obtain ergodic averages ^ J of equation (4.9) close to the desired pos-
terior expectation J, equation (4.10). Several formal convergence tests have been proposed
in the recent literature [7]. For example Gelman and Rubin [10] propose to consider several
independent parallel runs of the MCMC simulations. Convergence is then diagnosed if the
dierences of ^ J across the parallel runs are within a reasonable range. Another famous
convergence test was proposed by Geweke [13] and it is presented in the following Subsec-
tion. To better assess convergence of iterative simulation, it is recommended to compare
dierent independently simulated sequences (at least two), with starting points drawn from
an overdispersed distribution [12, Chap. 11].
4.3.1 Geweke test
In his work [13], Geweke recommends the use of methods from spectral analysis to assess
convergence of MCMC sampler when the intent of the analysis is to estimate the mean64 4 Sampling-based Bayesian approach for parameter estimation
of some function f of the parameter . The sequence f(k) computed with the simulated
samples can be regarded as a time series.
The Geweke method rests on the assumption that the nature of the MCMC process
and of the function f imply the existence of a spectral density Sf(!) for this time series,
that has no discontinuities at the frequency 0, i.e. there exists the nite value Sf(0). If
this assumption holds, then for the MCMC estimator (4.9) (  fNs()) of the expectation
E[f()] given by equation (4.10), based on Ns iterations of the algorithm, the asymptotic
variance is Sf(0)=Ns. The square root of this asymptotic variance can be used to estimate
the standard error of the mean. Geweke's convergence diagnostic after Ns draws of the
MCMC sampler is calculated by taking the dierence between the means  fA(), based on
the rst nA iterations, and  fB(), based on the last nB iterations:
 fA() =
1
NA
NA X
k=1
f(k) (4.15a)
 fB() =
1
NB
Ns X
k=n
f(k) (4.15b)
where 1 < nA < n < Ns and nB = Ns   n + 1, and dividing by the asymptotic standard
error of the dierence, computed from spectral density estimates ^ SA
f (0) and ^ SB
f (0) for the
two dierent pieces of the sequence. If the ratios nA=Ns and nB=Ns are xed, with
nA + nB
Ns
< 1; (4.16)
and if the sequence f(k) is stationary, then by the central limit theorem, the distribution
of this diagnostic tends to a standard normal distribution as Ns tends to 1:
ZNs =
 fA()    fB()

^ SA
f (0)
NA +
^ SB
f (0)
NB
1=2
d         !
Ns!1
N(0;1) (4.17)
Thus the value ZNs can be used to test the null hypothesis of  fA() =  fB() and if this
is rejected then it indicates that the chain has not converged yet. Geweke suggests taking
nA = Ns=10 and nB = Ns=2 [4, 7].4.4 Results on simulations: quality of data t 65
4.4 Results on simulations: quality of data t
With the support of the Matlab toolbox Mcmcstat, we estimated the model parameter
 by sampling from the posterior distribution p(jy), as explained in the rst Sections 4.1,
4.2 and 4.3 of this Chapter.
In this Section we present and compare the results for both ODE models (2.3) and (2.6)
obtained with the considered Bayesian approach, in particular the simulated trends of the
steady state lipid levels in response to the dierent experimental conditions dened by the
activity of the enzyme SMS1 (value of the input u).
Having a wide set of estimated parameters k, k = 1;:::;Ns, obtained by sampling
from the posterior distribution inside the prior support region (the orders of magnitude
are 105 samples for the rst model and 106 for the second one), an interesting analysis
concerns the predictive power of the two models, evaluated in terms of their ability to t
the experimental data.
The idea of prediction of a model falls within the concept of making inference about
an unknown observable quantity of interest, and in our practical case it consists in the
computation of the distribution over all possible outputs of the model, i.e. the steady
state solutions  zi;u;i = 1;2;3;u = 1;2:2;0:77, given the knowledge of the dataset y. This
concept can be formally expressed by the posterior predictive distribution p( zi;uj~ y), already
presented in Section 4.1, where we consider the logarithm of the measurements, as explained
in Section 3.2 about the statistical model:
p( zi;uj~ y) =
Z
p( zi;u;j~ y)d Marginalization (4.18a)
=
Z
p( zi;uj; ~ y)p(j~ y)d Factorization of the joint distribution (4.18b)
=
Z
p( zi;uj)p(j~ y)d  zi;u is independent of ~ y given  (4.18c)
Also in this context concerning the sampling from the posterior distribution, for all simu-
lations the estimation of parameter was carried out in logarithmic scale with a log-uniform
bounded prior distribution p(), spanning over four orders of magnitude, like in the previ-
ous case of the MLE, explained in Section 3.3. In this way the model parameter is expressed66 4 Sampling-based Bayesian approach for parameter estimation
as  = 10  and what the sampling algorithm estimates is a set of possible values for the
log-transformed parameter   = log10 .
As concerns the bounds dening the prior distributions over all parameters we consid-
ered the interval values reported in the Tables 3.1 and 3.2, for the two dynamical models
(2.3) and (2.6), respectively. Such support regions were centred approximately around the
values of the maximum likelihood estimates ^  MLE.
4.4.1 Bayesian estimation results of the model without feedback
Considering the dierential equation model (2.3), that describes the biochemical system
using the hypothesis of constant ceramide in
ux at the TGN, represented by the parameter
Cin, we carried out the sampling from the posterior distribution p(j~ y) to estimate a set
of possible values for the model parameter  = (Cin;p1;p2;d1;d2;d3;k1;k2) 2 R8
+, and
afterwards we used these parameters for predictions of the model.
From a practical point of view we carried out the estimation of the log-transformed
parameter   = log10 , inside the prior support regions listed in Table 3.1. To do this we
employed the algorithm oered by the Matlab function mcmcrun, choosing the \DRAM"
sampling method, from the mcmcstat toolbox (see Appendix A).
Before performing the main run, a warm-up/tuning of the covariance based proposal
distribution was carried out by simulating a sample of size 104, while in the subsequent
main run we generated a chain of size of 8106. Moreover to speed up the MCMC simulation
and to have more samples of the parameter to analyse, two independent Markov chains
of the same dimension were started in parallel. The acceptance rate was almost 58% for
both chains. To test the convergence of the two Markov chains to the desired posterior
distribution we used the Geweke method implemented inside the mcmcstat toolbox. In
the considered simulation both chains and also the resulting merged chain obtained by
concatenation of the two (consisting of 1.6 million samples for the parameter vector) passed
the convergence test with a p-value of at least 0.9 in each sub-dimension, attesting the
occurred convergence. Further details about the simulation can be obtained directly in the4.4 Results on simulations: quality of data t 67
Matlab code reported in Appendix A.
In Figure 4.1 we can observe the trajectories of the three lipid concentrations relative
to the three experiments, generated with 1000 dierent MCMC estimated values of the
model parameter vector  extracted from the posterior distribution p(j~ y), according to
the considered bounded prior distribution. We highlight with a continuous line, together
with the new presented trajectories, also that simulated using the MLE parameter vector
^ MLE. We can notice that all trajectories simulated using the samples k are spread in
a region around the MLE generated trajectories for each lipid and each experiment, and
moreover also in this context the general trends of such trajectories are similar to those
relative to the maximum likelihood estimate.
The most interesting result is that, considering a single estimated value k for the
parameter vector, the respective simulated ceramide levels are constant and assume the
same value for each experiment (see the rst line of plots), as it happens also with the
the maximum likelihood estimation applied to the rst ODE model without feedback (see
Section 3.3). This means that even the estimation by sampling from the posterior dis-
tribution p(j~ y) gives as most likely resulting parameters those that leave the ceramide
levels constant across all three experiments, since the considered model cannot capture the
qualitative behaviour of ceramide at steady state in response to changes of the enzyme
activity.
Figure 4.2 represents the posterior predictive distributions of the outputs of the model
at steady state p( zi;uj~ y), i = 1;2;3 and u = 1;2:2;0:77, relative to the model (2.3) with-
out feedback, estimated from the MCMC samples using equation (4.18). This calculated
density of the predicted steady state solutions is represented with continuous dark grey
lines, that have a characteristic bell-shape centred approximately around the maximum
likelihood estimates. The maximum likelihood estimates are marked with a black vertical
straight line, while the normalized experimental data are plotted with vertical grey lines
with the respective normalized standard deviations marked also in grey with dotted lines.
The panels of Figure 4.2 are transposed compared to that of Figure 4.1 for better
comparison. From this Figure we can observe the same results, already highlighted by68 4 Sampling-based Bayesian approach for parameter estimation
Figure 4.1: Trajectories of the concentrations of ceramide, DAG and SM obtained with the
ODE model (2.3) with constant ceramide in
ux Cin simulated with the MCMC samples
drawn from the posterior distribution and with the MLE parameters of Table 3.1, plotted
together with the experimental data at steady state for the three dierent experimental
conditions.
the previous Figure 4.1, that conrm also the hypothesis of our theoretical investigations
described in Section 2.4. In fact we see in the rst column of plots how the steady state
levels of ceramide predicted by the model are constant across all the three experiments,
since the qualitative behaviour of ceramide for dierent experimental conditions cannot
be described by this model in the right way. The two panels of the Figure relative to the
posterior predictive distribution of ceramide steady states in the cases of overexpression
and silencing are identied with two black exclamation marks, because these are the cases4.4 Results on simulations: quality of data t 69
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Figure 4.2: Posterior predictive distributions of the steady state levels of ceramide, DAG
and SM for model (2.3).
in which the model fails to explain the experimental data relative to the changes of the con-
centrations of ceramide in response to SMS1 manipulations. Instead the predicted steady
state levels of DAG and SM are more sensitive to the changes of the SMS1 activity, showing
a signicant increase or decrease in the overexpression and silencing experiments, respec-
tively, compared to the control case. Moreover the posterior predictive distributions of the
steady state levels of DAG and SM are estimated to be very similar in each experimental
condition, capturing quite well the experimental results.70 4 Sampling-based Bayesian approach for parameter estimation
Finally one can notice that the variances of the model predictions are rather small,
especially in the case of ceramide. The largest variances can be seen in the overexpression
case for DAG and SM. This fact can be a hint that this rst model is wrong or nor 
exible
enough, such that it cannot well capture all experimental data.
4.4.2 Bayesian estimation results of the model with feedback
In this Subsection we report the results of the MCMC sampling relatively to the modied
ODE system (2.6), that considers the feedback regulation term Cin(DAG) = a  DAG in
the place of the simple constant ceramide in
ux Cin. Considering this model we carried
out the sampling from the posterior distribution p(j~ y) to estimate a set of possible values
for the model parameter  = (a;p1;p2;d1;d2;d3;k1;k2) 2 R8
+, and consequently used these
parameters for predictions of the model. The technical details for the estimation and the
employed algorithm are the same described in the previous Subsection.
A warm-up/tuning of the covariance based proposal distribution was performed by
simulating a sample of size 104, as in the case of the rst model, while in the subsequent
main run we generated a larger chain of size of 3106, having encountered more diculties
to reach the convergence to the desired posterior distribution. Also in this case two Markov
chains of the same dimension were started in parallel. The acceptance rate was about 32%
for both chains. As regards the convergence test, in the considered simulation both chains
and also the resulting merged chain obtained by concatenation of the two (consisting of 6
million samples for the parameter vector) passed the convergence test with a p-value of at
least 0.8 in each sub-dimension, attesting the occurred convergence. Further details about
the simulation can be obtained directly in the Matlab code reported in Appendix A.
Figure 4.3 shows the trajectories of the three lipid concentrations relative to the three
experiments, generated with 1000 dierent MCMC estimated values of the model parameter
vector  extracted from the posterior distribution p(j~ y), according to the considered log-
uniform bounded prior distribution, whose boundaries are listed in Table 3.2.
Also in this case all trajectories simulated using the samples k are spread in a region4.4 Results on simulations: quality of data t 71
around the trajectories obtained with the MLE, following the same trend of these last, with
dierent densities or width of the trajectory distributions depending on the particular lipid
or experiment.
Figure 4.3: Trajectories of the concentrations of ceramide, DAG and SM obtained with the
ODE model (2.6) with feedback regulation Cin(DAG) simulated with the MCMC samples
drawn from the posterior distribution and with the MLE parameters of Table 3.2, plotted
together with the experimental data at steady state for the three dierent experimental
conditions.
As most interesting result we can immediately notice how in this second case there is a
very dierent behaviour of the simulated trajectories of ceramide across the three dierent
experiments. Unlike the constant trend of the trajectories of ceramide predicted by the
rst model without feedback (see Figure 4.1), in this case we observe that such trajectories72 4 Sampling-based Bayesian approach for parameter estimation
simulated with the modied model are more sensitive to the manipulation of SMS1 activity
compared with the original model and they follow in a qualitative way the trend of the
experimental data.
Figure 4.4 shows the posterior predictive distributions of the simulated steady state
levels p( zi;uj~ y).
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Figure 4.4: Posterior predictive distributions of the steady state levels of ceramide, DAG
and SM for model (2.6).
While the distributions relative to DAG and SM look very similar to those of Figure 4.2,
even though the MLE and hence the prior support regions are very dierent from those of4.4 Results on simulations: quality of data t 73
model (2.3), the main dierence, as already underlined, can be seen in the ceramide steady
state levels. These are in fact now more sensitive to the changes of the enzyme activity,
and ceramide shows an increase after SMS1 overexpression and a less pronounced decrease
after silencing. This is in accordance with the data and thus conrms the hypothesis
that the model including the feedback regulation term is qualitatively able to capture the
experimental ndings.
4.4.3 Marginal parameter distribution
In this Subsection we present the results concerning the computation of the marginal
posterior distributions for each single parameter i relative to both ODE models (2.3) and
(2.6), calculated using the formula (4.11). In practice the computed marginal distributions
are all relative to the components of the log-transformed parameter   = log10 . We
highlight another time the fact that we chose the boundaries for the log-uniform prior
distributions taking intervals of 4 orders of magnitude centred around the values of the
maximum likelihood estimated parameter vector ^  MLE. This can be easily noticed in
the two following Figures 4.5 and 4.6, which represent the considered marginal posterior
distributions for the two dierent ODE models. Figure 4.5 shows the marginal distributions
p( ij~ y) relative to the rst ODE model (2.3), with:
 i 2 flog10 Cin;log10 p1;log10 p2;log10 d1;log10 d2;log10 d3;log10 k1;log10 k2g:
These distributions were generated by kernel density estimation from the obtained MCMC
samples, and they are plotted in the Figure together with the maximum likelihood esti-
mates, marked with dark grey vertical lines, and with the 5% and 95% percentiles, marked
with grey dotted lines. We can observe that the marginals of the ceramide production, Cin,
of the ceramide degradation rate, d1, and of the forward Michaelis-Menten constant, k1,
are almost uniform over the intervals of the prior distribution. This result highlights the
fact that data provide little information about these parameters and demonstrates that
within the given prior support no particular model parametrization better explains the74 4 Sampling-based Bayesian approach for parameter estimation
data. The marginals of the other 6 parameters are slightly more informative, although all
parameters remain only vaguely determined over several orders of magnitude.
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Figure 4.5: 1D Marginals of log-transformed model parameters estimated by Monte Carlo
integration from MCMC sampling relative to the ODE model (2.3).
As regards the modied ODE model (2.6), the relative parameters' marginal posterior
distributions are plotted in Figure 4.6. We notice that in this case we can derive more
information about the distribution of parameters, since the variances of the marginal dis-
tributions are slightly smaller, in particular for the parameters a and d1. Nevertheless, also
in this case concerning the revised model, parameters are not determined in a precise way,
and this fact suggests that a lot of dierent parametrizations could reproduce the good t
quality.
4.4.4 Comparison of the results of the two models
Summarizing the results of the two previous Subsections, now we want to make a com-
parison between the features of the two ODE models. We can maintain that, overall, the
results obtained with the parameter estimation by sampling from the posterior distribution4.4 Results on simulations: quality of data t 75
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Figure 4.6: 1D Marginals of log-transformed model parameters estimated by Monte Carlo
integration from MCMC sampling relative to the ODE model (2.6).
p(j~ y) conrm our theoretical analysis described in Section 2.4, concerning the qualitative
changes of the steady state lipid composition in response to SMS1 manipulation, and also
the results of the simulations of the MLE, presented in Section 3.3.
First of all we can arm, in general, that the rst model (2.3) with constant ceramide
in
ux Cin is not able to capture qualitatively the experimentally observed changes of the
steady state ceramide concentrations following manipulations of the activity of the enzyme
SMS1 that drives the considered reaction. In fact all parameter estimations produce as
most probable value of the estimated parameter vector the one that leaves the concentra-
tion of ceramide constant across all experiments, since the model would predict changes
of such steady state levels in the opposite direction with respect to that observed in the
experimental results. Besides the results of this Bayesian analysis, the mathematical in-
vestigation of Section 2.4 proves that, regarding the chemical reaction in isolation, i.e.
without considering the feedback term, the changes in lipid steady state levels of both
sides of the reaction must have opposite signs in response to changes in SMS1 activity, and76 4 Sampling-based Bayesian approach for parameter estimation
this outcome holds independently of the exact kinetics modelling the reversible enzymatic
reaction. In this way both analytical and statistical results qualitatively reject model (2.3).
Instead the modied dierential equation system (2.6) that includes the positive feed-
back regulation from DAG level to ceramide presents a highly improved data t quality.
In fact in this case the changes in ceramide levels in response to SMS1 manipulations can
qualitatively be captured for a wide range of estimated parameter values.
Even though the marginal posterior distributions of the single components of the model
parameter are not so informative also in the considered revised model, and the parameters
remain vaguely determined over several orders of magnitude, we obtain anyway a signicant
improvement of the data t, and the predictions of the model can capture the qualitative
behaviour of the experimental ndings.Conclusions
Summary of results and discussion
The aim of this thesis was to build a dynamic mathematical model, based on chemical reac-
tion kinetics, in order to describe the reversible metabolic conversion of ceramide (Cer) and
phosphatidylcholine (PC) into sphingomyelin (SM) and diacylglycerol (DAG), catalysed
by the enzyme sphingomyelinsynthase 1 (SMS1). As experimental dataset to be used for
model parameter estimation, we considered lipid concentrations at steady state, measured
under dierent experimental conditions in which the activity of SMS1 was altered. In re-
sponse to these SMS1 manipulations, changes in lipid composition were observed and we
aimed at describing qualitatively these results with our mathematical model. We proved
that a simple model that considers the reversible reaction in isolation fails to explain the
considered experimental ndings. In particular, changes of ceramide levels at steady state
in response to SMS1 overexpression and silencing could not be captured by the model.
Consequently to these results, and based on biological knowledge, we modied the rst
ODE model by considering a positive feedback regulation from DAG to ceramide, and
thus modelling the in
ux of this last lipid at the TGN as an increasing linear function of
the concentration of DAG. The validity of this choice to improve our dynamical model was
demonstrated both in a theoretical way, using the hypothesis of the Implicit function the-
orem, and with statistical inference approaches. In fact, using MLE- and sampling-based
statistical methods, we showed that a simple linear feedback term was sucient to explain
the observed data qualitatively, with a signicant improvement of the quality of t.
7778 Conclusions
We underline the fact that, even though we used dynamic models (dierential equation
systems) to describe the SMS1 driven reaction, what in
uences the parameter estimation
is only the equilibrium situation of the system, since all measurements are steady state
lipid concentrations. This means to consider the system at steady state, i.e. f( x;) = 0.
From the obtained results we maintain that feedback regulation might be an essential
feature of the SMS1 driven conversion of ceramide into SM, and that the eects caused
in vivo by this feedback control may not be explained by a model that considers the
reversible reaction in isolation. In this study we have motivated the existence of such
a feedback regulation with an indirect in
uence of DAG on the eciency of ceramide
transport to the trans-Golgi network, regulated by protein kinase D (PKD) and by the
ceramide transport protein CERT [41]. Anyway we cannot arm with certainty that this
biochemical pathway has the principal contribution to the studied feedback regulation. In
fact, there could be other unknown causes that underlie this phenomenon, and moreover
the eects on ceramide levels in response to modulation of the activity of SMS could be
dierently regulated depending on the specic cellular context. From a biological point of
view, a precise knowledge about this reaction taking place at the trans-Golgi network is
not yet available, and further research should be conducted. For this reason we have to
pay attention about the conclusions that we draw from our results, even if we maintain
that further investigation in the direction of the feedback regulation should be supported.
Besides these considerations concerning the biological fundamentals of this thesis, we have
to be careful about the meaning that we attribute to the obtained results. In fact, our
study clearly shows that model errors can have a drastic eect on parameter estimation.
For example, as we described in detail in Sections 3.3 and 4.4 concerning the results
of parameter estimation, we can notice that the estimated parameters for the two ODE
models, which dier formally only for the single term Cin, show dierences for several orders
of magnitude. Moreover we can notice that the choice of model parameter boundaries is
extremely in
uential on the predictive power of the ODE model, and in general it is
an important aspect in the construction of mathematical models describing biochemical
cellular reaction networks. These facts put parameter values estimated from experimental79
data and simple models much into question, and moreover justify the use of statistical
sampling methods, which also provide information about uncertainties due to modelling
errors.
Future work
As already underlined, from a biological point of view it would be fundamental to further
investigate the functioning of the complex secretion regulatory network, in particular the
dynamic relations between the lipids involved in the SM synthesis reaction, in order to
bring interesting improvements and future possible developments of this study.
Additional investigation of the revealed feedback mechanism could be developed and
supported by other experimental datasets. In particular, from a modelling point of view,
time series data of lipid concentrations would bring much more information for estimat-
ing model parameters, improving in this way also the investigation of parameter bounds.
Finally it would be interesting to consider dierent cellular systems, to have a general
overview of the problem and to understand possible similarities and dierences.80 ConclusionsAcknowledgements
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Programming with Matlab
All basic numerical computations have been performed using the software Matlab, ver-
sion R2010b (32 bit). For the denition of the model and the management of the ex-
perimental data the toolboxes Sbpd and Sbtoolbox2 [34] have been used, which oer
specically a powerful environment in which to build models of biological systems. For
the numerical integration of the dierential equation systems (2.3) and (2.6) the toolbox
Sbtoolbox2 employs the particular integrator CVODE from Sundials1, which is a solver
for sti and non-sti ordinary dierential equation (ODE) systems (initial value problem)
given in explicit form [6]. As options for the absolute and relative error tolerances of the
MEX integrator in the case of the rst model we set to at least options.abstol=1e-12 and
options.reltol=1e-12. Instead for the second ODE model, having diculties to carry out
the integration of the ODE system, we used less strict constraints (options.abstol=1e-6
and options.reltol=1e-6), and moreover, to avoid the error CV TOO MUCH WORK that oc-
curred during the simulation with Matlab caused by stiness problems, we increased the
number of maximum internal steps to options.maxnumsteps=1000000.
1https://computation.llnl.gov/casc/sundials/
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A.1 Project internal structure
To employ the toolboxes Sbpd and Sbtoolbox2 we need a precise structure of the project,
in which we dene the model, the experimental data (measurements) and the dierent ex-
periments. In practice our project consists of two folders for the simulations relative to
the two dierent ODE models (2.3) and (2.6). Each project-folder must contain in par-
ticular two specic subfolders: (1) subfolder \models", in which we put the les with
the denition of the ordinary dierential equation models (e.g. modelName.txt) (2) sub-
folder \experiments", which contains other subfolders, with particular les describing the
experiments (e.g. experiment1.exp contained in the folder Experiment1).
In this Section we describe in particular all details relative to the rst ODE model
without the positive feedback term, since, from the informations already given in the
text about some simulations' details, one can easily obtain the code for the simulations
concerning the second ODE model with feedback. In Table A.1 are presented the specic
subfolders and les contained in the project-folder relative to the simulations for the rst
ODE model.
Table A.1: Project folder: SMS1 Project 1.
Folder Contained subfolders and les
models SMS1 model noFB.txt
experiments Experiment1 ! experiment1.exp
Experiment2 ! experiment2.exp
Experiment3 ! experiment3.exp
Experiment4 ! experiment4.exp
A.1.1 ODE model and experiments
The code written in the le SMS1 model noFB.txt, dening all properties of the ODE
model without feedback is:A.1 Project internal structure 85
********** MODEL NAME
SMS1 Reaction system 1
********** MODEL NOTES
First model, where Cin = constant.
All variables are dimensionless (normalized) and parameters have physical units.
PC and u are considered as parameters, and their values are specified
for each experiment. There are 10 parameters, but only 8 (without u and PC)
are estimated.
State variables:
x1 = Cer; x2 = DAG; x3 = SM
Parameters:
Cin, p1, p2, d1 = dC, d2 = dDAG, d3 = dSM, k1, k2, u = SMS, PC
Parameters are estimated in logarithmic scale.
The outputs are defined as logarithm of the state variables,
because we use a log-normal distribution error model.
********** MODEL STATES
d/dt(x1) = s1 - s4*x1 - s2*u*x1*PC/(x1*PC+s7) + s3*u*x2*x3/(x2*x3+s8)
d/dt(x2) = - s5*x2 + s2*u*x1*PC/(x1*PC+s7) - s3*u*x2*x3/(x2*x3+s8)
d/dt(x3) = - s6*x3 + s2*u*x1*PC/(x1*PC+s7) - s3*u*x2*x3/(x2*x3+s8)
x1(0) = 1
x2(0) = 1
x3(0) = 1
********** MODEL PARAMETERS
Cin = 1
p1 = 1
p2 = 1
d1 = 1
d2 = 1
d3 = 186 A Programming with Matlab
k1 = 1
k2 = 1
u = 1
PC = 1
********** MODEL VARIABLES
Cer = log(x1)
DAG = log(x2)
SM = log(x3)
s1 = 10^Cin
s2 = 10^p1
s3 = 10^p2
s4 = 10^d1
s5 = 10^d2
s6 = 10^d3
s7 = 10^k1
s8 = 10^k2
********** MODEL REACTIONS
********** MODEL FUNCTIONS
********** MODEL EVENTS
********** MODEL MATLAB FUNCTIONS
We report also as example the code contained in the le experiment1.exp relative to the
description of the rst experiment, in which we considered the values taken from [8]:
********** EXPERIMENT NAME
Experiment 1 for SMS1 Reaction system 1
********** EXPERIMENT NOTES
The input u expresses the SMS1 activity (% of WT-control).
PC is considered constant in the model (dPC/dt = 0), the value set for this
experiment is the one given in the table, considering only the mean withoutA.1 Project internal structure 87
SD, normalized to the value of the control experiment.
In this experiment there is no SMS1 overexpression or knockdown.
********** EXPERIMENT INITIAL PARAMETER AND STATE SETTINGS
u = 1
PC = 294/294
********** EXPERIMENT PARAMETER CHANGES
********** EXPERIMENT STATE CHANGE
A.1.2 Structure of the main script
We present here an itemized scheme of the steps constituting the main Matlab script for
the simulations.
 Enable the parallel language features in the Matlab language (e.g. parfor) by cre-
ating a special job on a pool of workers for parallel computation, using the Matlab
function matlabpool.
 Create a new SBmodel from the text le with extension .txt containing the descrip-
tion of the model, using the Matlab function
model = SBmodel('SMS1 model noFB.txt').
 Dene random initial conditions for the state variables xi(0); i = 1;2;3.
 Convert the SBmodel to a high performance \Matlab EXecutable C-code" (MEX)
model and link it with the CVODE integrator from Sundials, using the Matlab
function SBPDmakeMEXmodel.
 Prepare a special experiment project structure, named expStruct, containing the
description and the features of each of the four experiments.
 Read all experimental data from the excel le containing the normalised mean values
and standard deviations for the three lipids concentrations Cer, DAG and SM, using
the function BioDataImport.88 A Programming with Matlab
 Using the instruction RelDataCruncherAdv(model,expStruct), process the data for
a MEX based parameter estimation.
 Translate data in logarithmic scale and enhance the time vector, with the function
PEenhanceTvector.
 Dene the lower and upper bounds for each of the parameters to be estimated.
 Start the constrained optimization to maximize the likelihood function and thus nd
the MLE parameter vector ^ MLE, giving minus the logarithm of the likelihood as
input of the optimizing function fmincon.
 Merge the SBmodel with all 4 dened in silico experiments using the function
SBmergemodexp, and simulate it with the estimated MLE parameter vector ^ MLE
using the function SBPDsimulate, in order to obtain the relative trajectories of the
three state variables, i.e. the three lipid concentrations of Cer, DAG and SM.
 Run the burn-in sampling, dening dram as adaptation method, and afterwards the
sampling main run with two parallel Markov chains, using the function mcmcrun from
the Matlab toolbox mcmcstat.
 Chain merging and convergence analysis using the function geweke, always oered
by the toolbox mcmcstat.
 Computation of posterior predictive distributions of the model steady states and
of the one dimensional marginals of the parameter posterior distribution, using the
Matlab function ksdensity.
A.1.3 Matlab functions
In Table A.2 we report a list of all self-written functions and of the most important functions
already implemented in Matlab that we used in our code. For each method we specify
the usage code and a brief description of the specic function.
2http://helios.fmi./ lainema/mcmc/mcmcrun.htmlA.1 Project internal structure 89
Table A.2: Matlab functions.
Method Usage and Specic function
BioDataImport [stdv MuN] = BioDataImport('*.xls')
! imports *.xls data and produces *.csv les for each experiment and
calculates standard deviation cell variable following four dient rules.
RelDataCruncher [timevector, ISvalues, IPvalues, stdv0, expmodel,
Iparametervector]= RelDataCruncher(SBmodel, expStruct)
! preprocesses the data for a MEX based parameter estimation.
PErelativeHTspeed ! forms objective function (likelihood) to be optimized
fmincon [x,fval,exitflag,output,lambda,grad,hessian] =
fmincon(fun,x0,A,b,Aeq,beq,lb,ub,nonlcon,options)
! nds the minimum of constrained nonlinear multivariable function.
mcmcrun [results,chain,s2chain,sschain] =
mcmcmrun(model,data,params,options)
! Matlab function for the MCMC run. The user provides her own Matlab
function to calculate the "sum-of-squares" function for the likelihood part,
e.g. a function that calculates minus twice the log likelihood 2.
geweke [z,p] = geweke(chain,a,b)
Geweke's MCMC convergence diagnostic. Test for equality of the means of
the rst a% (default 10%) and last b% (50%) of a Markov chain.
ksdensity [f,xi] = ksdensity(x)
! computes a probability density estimate of the sample in the vector x. f
is the vector of density values evaluated at the points in xi. The estimate is
based on a normal kernel function, using a window parameter (width) that
is a function of the number of points in x.90 A Programming with MatlabBibliography
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